Investigation Of The Role Of The KATP Channel In Vascular Hyporeactivity In Sepsis by Buckley, James Francis
  
INVESTIGATION OF THE ROLE OF THE  
KATP CHANNEL IN VASCULAR 
HYPOREACTIVITY IN SEPSIS 
 
James Francis Buckley 
 
A thesis submitted to University College London, 
in part fulfilment for the degree of 
DOCTOR OF PHILOSOPHY 
 
 
Centre for Clinical Pharmacology 
Department of Medicine 
University College, London 
 
July 2012
Declaration 
 
 
Declaration of Work 
 
I, James Francis Buckley, confirm that the work presented in this thesis is my 
own. Where information has been derived from other sources, I confirm that this 
has been indicated in the thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
 3 
Abstract 
The lack of responsiveness of vascular smooth muscle cells (VSMCs) to 
vasopressor catecholamines is termed vascular hyporeactivity. Vascular 
hyporeactivity is an important component of sepsis. ATP-sensitive potassium 
channels (KATP) play a fundamental role in vascular hyporeactivity in long-term 
(>20hrs) sepsis. These channels remain in the open state, leading to membrane 
hyperpolarisation and subsequent relaxation of VSMCs.  However, the precise 
mechanism of KATP activation in sepsis has yet to be elucidated. Disruption of the 
actin cytoskeleton, the direct effect of nitric oxide and the metabolic state of the 
cell all activate KATP channels and are possibilities. Therefore, three hypotheses 
were investigated: 1). Disruption of the actin cytoskeleton alters KATP channel 
function 2). Nitric oxide exerts a direct effect on the KATP channel. 3). Metabolic 
derangement is responsible for altered KATP channel function.  
Using confocal microscopy and biochemistry, it was demonstrated that the actin 
cytoskeleton of VSMCs was not disrupted in sepsis, and is therefore an unlikely 
mechanism for KATP channel activation. There was, however, a functional 
impairment of vascular function, indicating a lack of correlation between structure 
and function in the context of the model investigated. That NO has a direct effect 
on the KATP channel, and is subsequently responsible for its altered function in 
sepsis was also inconclusive. Finally, using HPLC techniques, no evidence to 
suggest that altered levels of adenosine nucleotide phosphates cause dysregulation 
of the KATP channel in either in vitro or in vivo models of sepsis (despite evidence 
of functional impairment) was observed.
Abstract 
Therefore, in the context of the models used, none of the afore-mentioned 
mechanisms were shown to be responsible for the altered KATP channel observed 
in vascular tissue in sepsis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations 
 5 
Commonly used Abbreviations 
 
ABC       ATP-binding Cassette 
ADP       adenosine 5’ diphosphate 
AMP       adenosine 5’ monophosphate 
AOI       area of interest 
ATP       adenosine 5’ triphosphate 
ATPi / [ATP]I   intracellular adenosine  
triphosphate 
BKCa     large conductance  
calcium activated  
potassium channels 
BSA       bovine serum albumin 
cAMP        cyclic adenosine 3’, 5’ 
monophosphate 
cGMP        cyclic guanosine 3’, 5’  
monophosphate 
CO2        carbon dioxide 
COX-2       cyclooxygenase-2 
Deta NO       nitric oxide donor 
DMEM      Dulbecco’s modified Eagle’s  
medium 
DMSO       dimethylsulphoxide 
F actin       filamentous actin 
G actin       globular actin 
Abbreviations 
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GFP        green fluorescent protein 
HBSS     Hanks Balanced Salt Solution 
HEPES     hepes (4-(2hydroxyethyl) 
piperazine-          
 1(4-(2-hydroxyethyl)-1-
piperizineethanesulphonic 
acid) 
HPLC  high performance liquid 
chromatography 
hrs        hours 
IC50    half maximal inhibitory  
concentration 
IL        interleukin 
iNOS        inducible nitric oxide  
synthase 
K+        potassium 
KATP        ATP sensitive K+ channel 
KCB        potassium channel blocker 
KCL        potassium chloride 
KCOs        potassium channel openers 
kDa        kilodaltons 
kg        kilograms 
Kir  inwardly rectifying K+ 
channel 
KNDP          NDP sensitive K+ channel 
Abbreviations 
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KV        voltage-gated K+ channels 
KZ method/technique      Kallman Z-stack acquisition  
method 
LPS        lipopolysaccharide 
LTA        lipoteichoic acid 
mg        milligrams 
Mg2+        magnesium (divalent cation) 
mins        minutes 
ml        millilitres 
MOF           multi-organ failure 
mV        millivolts 
NBFs        nucleotide binding folds 
NDPs        nucleotide diphosphates 
NFκB        nuclear factor kappa B 
nM       nanomolar 
NO        nitric oxide 
NO synthase       nitric oxide synthase 
NTPs        nucleotide triphosphates 
PBS        phosphate buffered saline  
solution 
PE        phenylephrine 
pH        potential of hydrogen 
PKA        protein kinase A 
Abbreviations 
 8 
PNU37883A         4-morpholinecarboximide-N-
1-adamantyl-N’-
cyclohexylhydrochloride 
pS        pico siemens 
ROS        reactive oxygen species 
SEM        standard error of the mean 
SR        sarcoplasmic reticulum 
SUR        sulphonylurea receptor  
subunit 
TLR        toll-like receptors 
TNFα        tumour necrosis factor α 
uM        micromolar 
VSM        vascular smooth muscle 
WA        walker A motif 
WB        walker B motif 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
 9 
Acknowledgements 
 
I would like to give thanks to the following: 
 
To my primary supervisors, Professor Lucie Clapp and Professor Mervyn Singer 
for their guidance, tolerance and patience throughout my studies; 
 
Prof. Andy Tinker, Dr. Sue Hall and Dr. David Kelly for their help, support and 
advice with confocal microscopy. Dr. Rita Jabr, Dr. Andrew Wilson and Dr. Jon 
Giblin for their help with laboratory techniques, positive feedback and 
constructive criticism. Dr. Alain Rudiger for help with HPLC. Valerie Taylor and 
Raymond Stidwell for all of their help and hard work with the in vivo model; 
 
To Drs Emilia Falcetti and Brian Tennant, previous members of the Clapp 
laboratory, for their friendship and advice; 
 
To my long-suffering partner, Dr Tabasum Farzaneh, who has been a pillar of 
support and encouraged throughout; 
 
Special thanks to the British Heart Foundation, who sponsored this work, and 
without whom this work would not have been possible. 
 
 
 
 
Contents 
 10 
Contents 
 
Declaration of work        2 
 
Abstract         3  
 
List of Abbreviations        5 
  
Acknowledgements        9 
   
List of Figures        16 
  
 
Chapter One: Introduction       22 
 
1.1 General introduction       23 
 
1.2 Pathophysiology of sepsis      24 
1.2.1 Toll-like receptors as pattern-recognition molecules for the innate immune 
system          24 
1.2.2 Pro-inflammatory and anti-inflammatory signalling in sepsis 26 
 
1.3 Septic shock and multi-organ failure    26 
1.3.1 Current management of septic shock     27 
 
Contents 
 11 
1.4 Potassium Channels       28 
1.4.1 Molecular biology of KATP channels     29 
1.4.2 Basic properties of KATP channels     35 
1.4.3 Pharmacological regulation      35 
1.4.4 Cellular functions of KATP channels     36 
1.4.5 KNDP channel        37 
1.4.6 KATP channels and vascular tone     38 
1.4.7 Hormonal regulation of KATP channels    39 
 
1.5  KATP channels in the pathophysiology of sepsis   41 
1.5.1 Vascular hyporeactivity      41 
1.5.2 In vivo models of sepsis      43 
1.5.3 In vitro models of sepsis      46 
1.6. Factors that might contribute to KATP channel opening  46 
1.6.1 Nitric oxide and KATP channels in sepsis    46 
1.6.2 Calcitonin Gene-Related Peptide and KATP channels in sepsis 47 
1.6.3 The actin cytoskeleton: not just scaffolding for KATP channels? 48 
1.6.4 Changes in energy status in sepsis     50 
1.6.5 Altered KATP channel expression in sepsis    51 
 
1.7 Role of BKca channels in sepsis     53 
1.7.1 Vascular hyporeactivity      53 
1.7.2  Regulation of immune function     53 
 
1.8 Cellular metabolism       54 
Contents 
 12 
 
1.9 Hypothesis        56 
 
Chapter Two: Materials and Methods     58 
 
2.1 Animal dissection       59 
 
2.2 In vitro model of sepsis      59 
 
2.3 In vivo model of sepsis      60 
 
2.4 Organ bath studies       62 
2.4.1 Endothelium intact experiments     62 
2.4.2 Functional assessment of blood vessels used in microscopy  65 
2.4.3 KATP channel pharmacology in the in vitro model of sepsis  65 
2.4.4 Assessment of the effects of Deta NO on KATP channel pharmacology 
         65 
2.4.5 Assessment of KATP channel pharmacology ex-vivo using the faecal 
peritonitis model of sepsis      68 
 
2.5 Immunostaining of frozen sections     68 
 
2.6 Confocal microscopy      69 
 
2.7 Tissue homogenisation and alpha actin separation  72 
Contents 
 13 
 
2.8 Western Blotting       73 
 
2.9 Griess Assay        76 
 
2.10 Protein Assay       79 
 
2.11 Tissue sample preparation for HPLC    81 
 
2.12 High performance liquid chromatography   81 
2.12.1 HPLC buffers        82 
2.12.2 Adenine nucleotide standard solutions    83 
 
2.13 Drugs and solutions       83 
 
2.14 Statistical analysis       84  
 
Chapter Three: Does cytoskeletal disruption occur in an in vitro model of 
sepsis?         85 
 
3.1 Investigation of the cytoskeleton in an in vitro model of sepsis 86 
3.1.1 Vascular Hyporeactivity in an in vitro model of sepsis  86 
3.1.2 Summary of functional assessment of an in vitro model  93 
 
3.2 Confocal microscopy      93 
Contents 
 14 
3.2.1 Confocal method development     93 
3.2.2 Confocal image analysis      97 
3.2.3 Elastin autofluorescence      99 
3.2.4 F and G Actin Staining      102 
3.2.5 Confocal imaging and image analysis quality control  114 
3.2.6 Summary of confocal quantification experiments   118 
 
3.3 Assessment of α actin protein content by western blot  119 
3.3.1 Assessment of total α actin levels     119 
3.3.2 Separation of α actin into filamentous (F) and globular (G) components 
         121 
3.3.3 Assessment of F actin in 24 hr and 48 hr in vitro models of sepsis 124 
3.3.4 Summary of western blot experiments    128 
 
3.4 Discussion of results       128 
 
Chapter Four: Does Nitric Oxide directly enhance KATP channel function in 
sepsis?         134 
 
4.1 iNOS induction and NO production is involved in an in vitro model of 
sepsis         136 
 
4.2 Determination of the Deta NO concentration required to mimic NO 
release in an in vivo model of sepsis    139 
 
Contents 
 15 
4.3 KATP channel function in an in vitro model of sepsis  142 
 
4.4 Discussion of NO activation of the KATP channel   145 
 
Chapter Five: Does and altered metabolic state cause KATP channel 
dysfunction in an in vivo model of sepsis?     151 
 
5.1 Vascular hyporeactivity in an in vivo model of sepsis  152 
 
5.2 Abnormal control of the ion channel pore by the SUR  155 
 
5.3 Adenine nucleotide levels in vascular smooth muscle in an in vivo 
model of sepsis       159 
 
5.4 Adenine nucleotide levels in vascular smooth muscle in an in vitro 
model of sepsis       167 
 
5.5 Discussion        169 
 
Chapter Six: Summary and Discussion     178 
6.1 Discussion        179 
6.2 Implications for the vascular biology of sepsis   181 
6.3 Summary and conclusions      183 
6.4 Future directions       184 
 
Contents 
 16 
Bibliography         186 
 
List of Tables and Figures 
 
Chapter One  
 
1.1 Molecular structure of the KATP channel    32 
1.2 Table of the molecular structure, pharmacology and function of the KATP 
channels        34 
1.3 The KATP channel may be key to several pathophysiological processes in 
sepsis         41 
1.4 Mechanisms involved in vascular smooth muscle contractions 52 
1.5 Molecular components of the KATP channel    55 
 
Chapter Two 
 
2.1  Photograph of the surgical insertion of a venous line into the left external 
jugular vein in a male Wistar rat     62 
2.2 Schematic of a vessel divided into rings and then mounted in an organ 
both, and a sample trace from a cumulative concentration-response curve
 64 
2.3 Theoretical decay curves for Deta NO, 37°C, pH7.4   67 
2.4 Light pathways used in confocal microscopy    71 
2.5 Schematic representation of the separation of F and G actin  75 
Contents 
 17 
2.6 Example standard curve of nitrate concentration against absorbance at 
540nm         78 
2.7 Representative protein standard curve    80 
2.8 HPLC apparatus and setup      83 
 
Chapter Three 
 
3.1 Concentration-response curves to phenylephrine obtained in fresh tissue 
         88 
3.2 Phenylephrine concentration-response curves in mesenteric artery 
following 24 or 48hr incubation with LPS    89 
3.3 Phenylephrine concentration-response curves in an in vitro model of sepsis 
in rat aorta        91 
3.4 Levcromokalim concentration-response curves in an in vitro model of 
sepsis in rat aorta       92 
3.5 Schema for the evolution and development of confocal image acquisition 
         96 
3.6 Schema for the evolution and development of confocal image analysis 
         98 
3.7 Elastin autofluorescence stimulated by an Argon 488 laser  100 
3.8 Assessment of the autofluoresence of elastin in rings of mesenteric artery 
         101 
3.9 Specimen images of fresh mesenteric artery (10µm sections) stained for F 
and G actin         102 
Contents 
 18 
3.10 Specimen confocal images of rat aorta from the long term in vitro model 
of sepsis        103 
3.11 Quantification of F actin in aorta and mesenteric artery  105 
3.12 Quantification of G actin in sections taken from aorta and mesenteric 
artery         106 
3.13 F actin immunofluoresence in aortic sections taken after incubation in LPS 
         108 
3.14 Mean F actin immunofluoresence of rings of aorta exposed to LPS  
         110 
3.15 Mean F actin immunofluorescence in rat aorta obtained via KZ technique 
         112 
3.16 Mean F actin immunofluorescence in rat aorta obtained via KZ technique 
         113 
3.17 Staining of F actin with phalloidin following cytochalasin and LPS 
treatment        115 
3.18 Quantification of F actin staining in the aorta   116 
3.19 Images of F actin in positive controls using 1:20 phalloidin dilution 
         117 
3.20 Western blots of total α actin in rings of aorta at various time points +/- 
LPS         120 
3.21 F and G actin separation technique     122 
3.22 Western blots to show F actin separation    123 
3.23 Western blots of aortic tissue stained for F actin 1:10,000  126 
3.24 Staining for F actin using and anti-alpha actin antibody 1:50,000 127 
 
Contents 
 19 
 
 
 
Chapter Four 
 
4.1 Effects of the iNOS inhibitor 1400W on aortic vascular reactivity in an in 
vitro model of sepsis       137 
4.2 Effects of the iNOS inhibitor 1400W on the in vitro model of sepsis in 
mesenteric artery       138 
4.3 Deta NO theoretical decay curves based on the half-life of 20hr at 37°C, 
pH7.4         140 
4.4 Nitrate levels produced by Deta NO or LPS after 20hr incubation 141 
4.5 Levcromakalim relaxation curves in rat thoracic aorta taken from an in 
vivo model of sepsis       143 
4.6 Levcromakalim concentration response curve generated in the 
presence/absence of Deta NO      144 
4.7 EC50 values obtained from concentration-response curves for 
levcromakalim in rat tissue      145 
 
Chapter Five 
 
5.1 Ex vivo assessment of aortic vascular reactivity after 24 hr of in vivo sepsis 
in a rat model        153 
5.2 Ex vivo assessment of aortic vascular reactivity after 48 hr of in vivo sepsis 
in a rat model        154 
Contents 
 20 
5.3 Percentage reversal of levcromakalim-induced relaxation by the pore 
inhibitor PNU-37883A in aortic rings taken from an in vivo sepsis model 
         156 
5.4 Percentage reversal of levcromakalim-induced relaxation by the 
sulphonylurea inhibitor, glibenclamide in aortic rings taken from an in 
vivo model        157 
5.5 Percentage reversal by PNU-37883A/glibenclamide of levcromakalim-
induced relaxation in rings of abdominal aorta taken from the in vivo 
model         158 
5.6 Standard curve for ATP measurement using HPLC   159 
5.7 Standard curves for ADP & AMP measurement using HPLC 160 
5.8 Measurement of adenine nucleotides in rat aorta, spiked with authentic 
nucleotides        161 
5.9 ATP levels from thoracic aorta, normalised to mg dry weight of tissue 
         163 
5.10 ATP levels from thoracic aorta, normalised to mg dry weight of tissue 
         163 
5.11 ADP levels from thoracic aorta, normalised to mg dry weight of tissue 
         164 
5.12 ADP levels from thoracic aorta, normalised to mg dry weight of tissue 
         165 
5.13 AMP levels from thoracic aorta, normalised to mg dry weight of tissue 
         165 
5.14 AMP levels from thoracic aorta, normalised to mg dry weight of tissue 
         166 
Contents 
 21 
5.15 ATP levels from thoracic aorta from an in vitro model of sepsis, 
normalised to mg dry weight of tissue    167 
5.16 AMP levels from rat thoracic aorta, normalised to mg dry weight of tissue 
in an in vitro model of sepsis      168 
 
Introduction 
 22 
 
 
 
 
 
 
 
Chapter One 
 
 
 
Introduction 
 
Introduction 
 23 
 
1.1 General introduction 
Sepsis (derived from the Greek for decay) is an infection-induced syndrome 
currently responsible for approximately 10% of all deaths worldwide (Tsiotou, 
2005). It is defined as a systemic response to infection, with an abnormal 
temperature (>38 oC or < 35 oC), deranged leukocyte count (> 12.109 or < 4.109 
cells/ml). It was first coined as a separate clinical syndrome by Bone and 
colleagues in 1989 (Bone, 1989), and has an annual incidence of 51 per 100,000 
population in the UK (Padkin, 2003). Despite decades of research, significant 
outcome improvements, particularly in the high mortality (40-60%) syndromes of 
shock (BP < 90 mmHg systolic or a drop of > 20 mmHg, despite adequate fluid 
resuscitation) and multi-organ failure (MOF: failure or more than two organ 
systems, i.e. cardiovascular, pulmonary, hepatic, renal or haematological) 
(Padkin, 2003; Brun-Buisson, 2004), have yet to be made. Numerous clinical 
trials have been conducted using agents that modulate inflammatory pathways; 
despite promising Phase II studies, these have generally failed to show any 
survival benefit (Angus, 2000; Eskandari, 1992; Petros, 1994).  
A novel therapeutic target is the ATP-sensitive (KATP) potassium channel; a 
channel that is critical in the adaptive response to stress. Indeed, pharmacological 
opening of these channels (e.g. with nicorandil) is already used therapeutically to 
treat angina pectoris while inhibitors (e.g. glibenclamide) are used in type II 
diabetes. Excessive activation of the KATP channel is becoming increasingly 
recognised as a major cause of hypotension and vascular hyporeactivity to 
catecholamines in septic shock. This has led some researchers to advocate that 
blocking these channels will be beneficial in shock (Landry, 1992; Vanelli, 1995; 
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Salzman, 1997). However, recent advances in the KATP channel field could 
suggest otherwise (Warrillow et al. 2006). Not only may the effectiveness of these 
inhibitors be substantially impaired in sepsis, but channel opening may actually 
represent a protective mechanism against the development of cellular dysoxia, 
mitochondrial dysfunction and decreased energy production, all common features 
in MOF. 
 
1.2  Pathophysiology of sepsis 
Genetic (Arcaroli, 2005), cellular (Tracey, 1986) and patient factors (e.g. co-
morbidities) can cause an infectious insult to trigger an inappropriately 
exaggerated and systemic inflammatory response. Various constituents of the 
micro-organism (e.g. cell wall components and DNA) bind to endothelial and 
white cell membrane-bound proteins as well as soluble proteins within the 
plasma, leading to a brisk innate and adaptive immune response (Shelley, 2003). 
This also leads to activation of endothelium, platelets and coagulation pathways 
(Levi, 1993). A comprehensive review of this topic has been published by various 
groups (Annane, 2005; Bochud, 2003) and (Hotchkiss, 2003). One such family of 
proteins which bind a host of pathogens are the Toll-like receptors (TLRs), which, 
when activated, lead to activation of nuclear transcription factors, including NF-
κB (Reviewed in (Akira, 2003) and (Liu, 2006 ).  
 
1.2.1 Toll-like receptors as pattern-recognition molecules for the innate 
immune system 
Originally studied in the Drosophila embryo, eleven different Toll-like Receptors 
(TLR 1-11) have now been identified in mammalian cells and they form part of 
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the interleukin 1 super family of receptors (Akira, 2003). At least seven of these 
receptors interact with microbial motifs, suggesting these receptors are important 
regulators of innate immunity. TLR4 recognises lipopolysaccharide (LPS or 
endotoxin), a gram-negative wall constituent (Cartwright, 2007), whilst TLRs 2 
and 6 recognise lipoteichoic acid (LTA), a gram-positive wall constituent 
(Cartwright, 2007). However, components of vertebrate cells are not recognised 
by TLRs, indicating their ancient origins and importance in the innate immune 
system. Toll-like receptors are expressed in human cells and importantly, TLR4 
mRNA and protein is found in vascular smooth muscle cells obtained from human 
saphenous veins (Sasu, 2001). Thus TLR4 may be an important target in the 
development of septic shock. There is a growing realisation that Gram-positive 
bacteria are an equally important cause of sepsis, with both peptidoglycan and 
LTA involved in the underlying pathophysiology (Wang, 2003). However, in this 
thesis I will concentrate almost exclusively on Gram-negative infections, where 
LPS has been extensively used as an experimental tool to mimic sepsis and 
elucidate cellular mechanisms of inflammation.  
 
Lipopolysaccharide, in order to stimulate TLRs, must either bind to the membrane 
bound CD14-receptor (Leturcq, 1996) and/or soluble CD14 in the plasma before 
forming a complex with TLR 4 and other adapter molecules (Cartwright, 2007). 
Once formed, it triggers various kinase signalling pathways, including IL-1 
receptor associated kinases (IRAKs), transforming growth factor β associated 
kinases (TRAKs) and the adapter protein MyD88, the combination of which leads 
to the upregultation of NF-κB and the transcription of a multitude of pro-
inflammatory genes (Cartwright, 2007; Liu, 2006; Akira, 2003). 
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1.2.2 Pro-inflammatory and anti-inflammatory signalling in sepsis  
TLRs up-regulate expression of a wide range of genes encoding for numerous 
pro-inflammatory cytokines (e.g. tumour necrosis factor α (TNFα) and 
interleukins-1 and -6), mediators, receptors and enzymes (e.g. the inducible 
isoform of nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) that 
increase production of nitric oxide (NO) and prostaglandins, respectively 
(Cartwright, 2007; Reddy, 2001; Tunctan, 2003; Oettinger, 1987). Stimulation of 
the arachidonic acid cascade generates pro-inflammatory prostaglandins, 
thromboxanes (Oettinger, 1987) and leukotrienes (Petrak, 1989). Activation and 
degranulation of neutrophils release reactive oxygen species (Kantrow, 1997; 
Singer, 1999) and proteases.  
 
This inflammatory response also includes an up-regulation of anti-inflammatory 
cytokines (e.g. IL-10) and mediators that attempt to suppress inflammation 
(Gerard, 1993), however a severe imbalance between pro- and anti-inflammatory 
cytokine production can lead to the clinical picture of the systemic inflammatory 
response syndrome (SIRS) (Annane, 2005; Bochud, 2003). This is defined as the 
clinical features of sepsis, but without evidence of infection.  
 
1.3 Septic shock and multi-organ failure 
The exaggerated inflammatory response results in increased vascular permeability 
with enhanced passage of fluid, plasma proteins, activated macrophages and 
neutrophils to extravascular compartments, a microcoagulopathy (Levi, 1993) and 
alterations in microvascular tone (Annane, 2005; Hotchkiss, 2003). A synergistic 
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effect between pro-inflammatory mediators and tissue hypoxia consequent to 
myocardial depression, hypovolaemia, interstitial oedema and blood flow 
redistribution will result in decreased mitochondrial energy production and a 
metabolic shutdown which, if severe enough, becomes clinically apparent as 
organ dysfunction (Singer, 1999).  
 
The septic process can affect most organ systems within the body. The most 
severe cardiovascular manifestation is septic shock, a condition defined as organ 
dysfunction with perfusion abnormalities plus hypotension (or a drop in systolic 
blood pressure of more than 40 mmHg) that does not respond to adequate fluid 
resuscitation. This results from a combination of excessive vasodilatation, 
vascular hyporeactivity (i.e. decreased responsiveness to catecholamines) and 
variable degrees of myocardial depression (Danner, 1991). 
 
1.3.1 Current management of septic shock 
Better knowledge of the mechanisms underlying shock will enable a more focused 
therapeutic strategy. Current management consists of adequate fluid resuscitation, 
inotropic and pressor support (e.g. norepinephrine) and adjuvant treatments such 
as corticosteroids (Annane, 2002). In the event of failure of norepinephrine to 
maintain an adequate blood pressure (e.g. mean arterial pressure > 60 mmHg), 
alternatives such as vasopressin can be tried (Russell, 2008). However, in certain 
cases, these are either not appropriate (e.g. because of pre-existing cardiac failure 
or mesenteric ischaemia), or patients fail to respond.  
A number of mechanisms are known to mediate vascular hyporeactivity and 
hypotension. These include the nitric oxide (NO) pathway (Thiemermann, 1990; 
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Petros, 1991; Hotchkiss, 1992) excess activation of potassium (K+) channels 
(Landry, 1992; Hall, 1996) and a relative reduction in the circulating levels of 
vasopressin (Landry, 1997). Large dose infusions of catecholamines can often be 
significantly reduced or even stopped after administration of a NO synthase 
(NOS) inhibitor (Petros, 1991) or vasopressin (Landry, 1997; Russell, 2008). 
These actions are likely to be mediated in part by closure of the vascular smooth 
muscle ATP-sensitive (KATP) channel (O'Brien, 2005; Wilson, 2002; Wakatsuki, 
1992), giving rise to membrane depolarisation and, ultimately, vasoconstriction. 
However, it is likely that KATP opening itself represents an independent 
mechanism underlying hypotension and vascular hyporeactivity (O'Brien, 2005; 
Wilson, 2002). 
 
1.4 Potassium Channels 
Potassium (K+) channels are membrane-spanning proteins that selectively allow 
movement of K+ ions across cells through a water-filled permeation pathway 
(pore) (reviewed in (Nelson, 1995). A gating mechanism (driven by a voltage 
change or ligand binding) switches the channel between open and closed 
conformations. Channel opening normally promotes K+ loss from the cell, 
resulting in membrane hyperpolarisation. Key roles for K+ channels include 
maintenance of the cellular resting membrane potential, regulation of neuronal 
excitability, neurotransmitter release, control of heart rate and smooth muscle 
tone, hormone secretion and epithelial electrolyte transport. Several hundred 
genes encoding for K+ channels have been identified; genetically, these broadly 
fall into three families; voltage-gated (including Kv and calcium-activated 
channels), inward rectifiers (Kir1-7.0) and twin pore K+ channels (Shieh, 2000). I 
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will concentrate on the role of the KATP channel and, specifically, its role in 
vascular hyporeactivity and hypotension in septic shock. Large conductance, 
calcium-activated K+ (BKCa) channels are also thought to play a role in vascular 
hyporeactivity in sepsis (Miyoshi, 1994) and this will be briefly discussed. 
 
 
1.4.1 Molecular biology of KATP channels  
The KATP channel is an integral membrane protein, ligand-gated, ATP-sensitive 
potassium channel which links the metabolic state of the cell to membrane 
potential. The KATP channel was first discovered in cardiomyocytes by Noma in 
1983 (Noma, 1983) and shown to be a channel inhibited by ATP. Structurally, the 
channel consists of two proteins; a central pore-forming subunit (Kir6.1/6.2), 
which is responsible for ion conduction and an associated sulphonylurea receptor 
subunit (SUR) (Fig 1.1). The pore of the KATP channel is a member of the inward 
rectifying family of potassium channels, allowing the efflux of potassium to 
repolarise the cell following membrane depolarisation. It exists in two isoforms; 
Kir6.1, encoded by the gene Kcnj8 in humans (Inagaki, 1995) and Kir6.2, 
encoded by Kcnj11 (Inagaki, 1995). Expression of Kir6.1 and Kir6.2 isoforms 
shows tissue variation conferring an element of tissue specificity as well as 
dictating biophysical characteristics. The ion channel protein is dependent on co-
expression with an SUR subunit to form a functional KATP channel (Inagaki, 
1995; Yamada, 1997). An –RKR- motif on the C terminus of the Kir6.2 is crucial 
for the normal trafficking of the Kir subunit to the membrane (Tucker, 1997) and 
a similar –RKQ- motif exists on the SUR (Bryan, 1999). The SUR is a member of 
the ATP-binding cassette (ABC) protein family and consists of 17 transmembrane 
domains with two intracellular nucleotide binding fold domains (Bryan, 1999). 
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The SUR subunit exists as two genes SUR1 (ABCC8) (Aguilar-Bryan, 1995) and 
SUR2 (ABCC9), though two major splice variants exist for SUR2, giving rise to 
either SUR2A (Inagaki, 1996) or SUR2B (Isomoto, 1996) proteins. SUR subunits 
also display tissue variability and pharmacology (Fig 1.2). For instance, the SUR1 
subunit is expressed in pancreatic β cells and has a greater affinity for the 
sulphonylurea agent, glibenclamide (an inhibitor of the KATP channel) than the 
SUR2B isoform, which is expressed in vascular smooth muscle (Fujita, 2000). 
The SUR also dictates responses to drugs that open the KATP channel (KCOs); 
diazoxide is able to activate pancreatic but not cardiac KATP channels (Fujita, 
2000).  
 
The stoichiometry of the two subunit proteins is not precisely known, but is 
thought to consist of a hetero-octameric complex, with a tetramer of the pore-
forming subunit surrounded by four SUR subunits, having a combined molecular 
mass estimated at 950 kD (Shyng, 1997). This combination was originally 
suggested because of the stoichiometry seen with other types of potassium 
channels, namely voltage-dependent potassium channels (Kv) and G-protein-
activated potassium channels (GIRK) (Fujita, 2000). This has been confirmed by 
studying current-voltage relationships of heteromeric mutant mouse Kir6.2 ion 
channels, along with expression of dimeric hamster SUR1-mouse Kir6.2 
constructs in COSm6 cells (Shyng, 1997). As outlined in the table, different 
compositions of Kir6.0/SUR will give rise to tissue-specific types of KATP 
channels. Broadly speaking, Kir6.2/SUR1 channels represent the main KATP 
channel in pancreatic β-cells and neurons, while Kir6.2/SUR2A is the major 
composition of channels in cardiac and skeletal muscle. Kir6.1/SUR2B constitutes 
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the 30-40 pS vascular channel (termed KNDP) that is relatively insensitive to ATP, 
but is activated by nucleotide diphosphates (NDPs) and inhibited by glibenclamide 
(see (Seino, 2003; Rodrigo, 2005) for review).  
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A. 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
Figure 1.1: Molecular structure of the KATP channel subunits: Transverse 
view (A) and cross-sectional view (B). The channel consists of two proteins: the 
ion-channel pore protein Kir, shown in red and the sulphonylurea receptor subunit 
(SUR) in blue. Mass = 950 kD (Shyng,1997). The Kir protein consists of two 
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transmembrane domains, with an intra-membrane loop. Both N and C terminals 
are intracellular. The SUR consists of a 17 transmembrane domain (TMD) 
protein, with an extracellular N terminus and an intracellular C terminus. There 
are two additional intracellular loops, known as nucleotide binding folds 1 
(NBF1) and 2 (NBF2), which bind ADP and Mg2+ ADP. This alters the ATP 
sensitivity of the ion channel pore. 
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Figure 1.2: Table of the molecular structure, pharmacology and function of KATP 
channels. References: a(Rodrigo, 2005), b(Miki, 2005), c(Shi, 2005), d(Mirshamsi, 
2005), e(Seino, 2005), f(Hanley, 2005), g(LaDisa, 2004), h(Tsuchiya, 2002), 
i(Clapp, 1998), j(Quayle, 1997), k(Landry, 1997), l(Humphrey, 1996), 
m(Wakatsuki, 1992), n(Das, 2003), o(Singer, 2005), p(Tricarico, 1997), q(Ardehali, 
2005).   
 
 
 
Tissue Subtype 
 
Function Pathophysiology Openers Closers 
Brain 
 
   (see Ref a, b, c for review) 
 
Kir6.1/SUR2A  
(neurones) 
(Kir6.2/SUR2B) 
sunstantia nigra 
 
(Kir6.2/SUR2) 
astrocytes 
 
Neuronal activity  
 
Neurotransmitter 
release 
 
Hypoglycaemic-
induced glucagon 
secretion 
 
Ischaemic preconditioning 
Ischaemic reperfusion 
Epilepsy & propagation of 
seizures 
 
 
Diazoxide 
 
Insulin, Leptin d 
 
 
Isoflurane, 
Glibenclamide 
Tolbutamide 
Heart 
 
   (see Ref a, e for review) 
 
 
Kir6.2/SUR2A  
(Kir6.2/SUR2B) 
Low open probability 
in normal 
physiological states  
 
Ischaemic 
preconditioning/reperfusion injury 
f, g 
 
Action potential shortening during 
metabolic stress 
 
Ventricular fibrillation 
 
Pinacidil, 
Nicorandil  
(coronary arteries, 
cardiomyocytes) 
 
 
Adenosine, insulin 
Glibenclamide 
HMR1098 
HMR1883 
Vasopressin h 
Endothelin, 
Angiotensin II  
Vascular smooth muscle 
 
   (see Ref a, i, j for review) 
 
 
Kir6.1/SUR2B 
most blood 
vessels 
 
*(Kir6.2/SUR2B) 
portal vein & 
mesenteric 
artery? 
Resting membrane 
potential in somoe 
vessels 
 
Regional tissue 
perfusion  
(e.g coronary & 
mesenteric 
circulation)  
Increased flow to hypoxic and 
energy deplete tissues  
 
Ischaemic 
preconditioning/reactive 
hyperaemia 
 
 
 
Hyporeactivity & hypotension in 
sepsis & haemorrhage shock k 
 
Levcromakalim 
Pinacidil 
Diazoxide 
Isoflurane 
(vasorelaxation & 
hypotension)  
 
 
 
CGRP, Adenosine 
PGI2, VIP, NO j 
 
Glibenclamide 
PNU 37883A 
 
Vasopressin  
Endothelin, 
Angiotensin II, 
Norepinephrine 
 
 
Smooth muscle (non-vascular) 
   (see Ref a for review) 
 
 
(Kir6.2/SUR2B) 
 
 
§(Kir6.2/SUR2B) 
urethra 
 
Modulation of 
contractility in colon, 
bladder & airway 
smooth muscle 
 
Unknown Levcromakalim, 
pinacidil 
Glibenclamide 
Pancreas 
   (see Ref b, e for review) 
 
 
Kir6.2/SUR1 
 
Insulin release 
 
Persistent hyperinsulinaemia of 
infancy 
Neonatal diabetes & some forms 
of adult diabetes 
Insulin resistance in sepsis? o 
 
Diazoxide, 
Levcromakalim, 
Pinacidil 
Glibenclamide 
Tolbutamide 
Gliclazide 
 
 
Skeletal muscle 
   (see Ref a, b for review) 
 
 
 
 
 
Subcellular 
Kir6.2/SUR2A 
(Kir6.2/SUR1) 
 
Glucose uptake 
 
 
Contractility during 
fatigue & recovery 
after fatigue 
 
Protection against ischaemic 
reperfusion injury 
 
K+ channel syndrome p 
 
Insulin resistance in sepsis? 
 
Diazoxide 
 
 
Insulin q 
Glibenclamide 
Mitochondria Mito(KATP)  
   (see Ref a, f, r for review) 
  
Unknown Matrix volume 
 
Metabolic regulation 
of mitochondrial 
membrane potential 
Ischaemic preconditioning 
 
Organ failure in sepsis 
Apoptosis  
 
Diazoxide 
Insulin 
Glibenclamide 
5-HD 
 
Potential subunit configuration or limited tissue expression is shown in brackets. *May underlie metabolically-sensitive channels in these tissues. §One of the 
few tissues to show KNDP-like current, but SUR1 may contribute.  
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1.4.2 Basic properties of KATP channels 
KATP channels containing Kir6.1/SUR2B subunits have single channel 
conductance of ~33pS (Yamada, 2000; Fujita, 2000) and are inhibited by 
intracellular ATP with an IC50 in the millimolar range. In contrast, Kir6.2/SUR1 
subunits have single channel conductance of around 60-80 pS and are typically 
inhibited by intracellular ATP with an IC50 in the micromolar range (Inagaki, 
1995; Fujita, 2000). This means that channel openings are relatively rare under 
normal physiological or resting conditions. However, substantial channel opening 
will occur in response to either a fall in ATP or a rise in Mg2+ADP. Thus, the ratio 
of ATP to ADP within the cell is often considered the key determinant of basal 
activity (Seino, 2003). ATP inhibits the channel by binding to the interface 
between two Kir subunits within the tetramer, interacting with the C-terminus of 
one subunit and the N-terminus of another (Antcliff, 2005). ADP, while having an 
inhibitory effect on the pore, will bind as Mg2+ADP to the Walker A motif of the 
nucleotide binding folds (NBFs) contained within the SUR, the net effect being to 
promote opening of the KATP channel (Gribble, 1997).  
 
1.4.3 Pharmacological regulation 
Pharmacologically, the channel is opened by a diverse group of drugs termed K+ 
channel openers (KCOs, e.g. levcromakalim, pinacidil and diazoxide) and closed 
by sulphonylureas (e.g. glibenclamide, tolbutamide, gliclazide). However, tissue 
selectivity and differences in potency exist with respect to these KATP channel 
modulators. For example, cardiac KATP channels are capable of activation by 
pinacidil, but are relatively unresponsive to levcromakalim and diazoxide, 
whereas pancreatic and vascular channels respond well to all these agents (Fig 
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1.2). Likewise, tolbutamide and glibenclamide potently inhibit pancreatic 
channels in the low nanomolar range but higher concentrations (<100 fold) are 
required to inhibit the vascular channel (Fujita, 2000). The situation is still more 
complex since KATP channels have two binding sites for sulphonylureas, a low 
affinity site (IC50 > 1.5 mM) on the Kir and a high affinity site (IC50 10-200 nM) 
on the SUR (Aguilar-Bryan, 1999; Fujita, 2000).  
 
The mechanistic action of KCOs is to increase the open probability (Po) of the 
channel, an effect that is triggered by a conformational change in the SUR upon 
binding of the drug. This conformational change requires that Mg2+ADP be bound 
to the Walker A motif on the NBF (Gribble, 1997). On the other hand, 
glibenclamide inhibits the binding of KCOs to the SUR (Dickinson, 1997; 
Hambrock, 1998; Loffler-Walz, 1998; Schwanstecher, 1998). This, in turn, 
prevents binding of Mg2+ADP to the NBF domains and allows the inhibitory 
effect of ATP on the Kir subunit to tip the balance in favour of KATP channel 
closure (Aguilar-Bryan, 1999).  
 
1.4.4 Cellular functions of KATP channels 
One of the functions of the KATP channel is to link the metabolic state of the cell 
to membrane excitability. Such a mechanism is responsible for insulin secretion in 
response to increasing levels of glucose in pancreatic ß cells (Eliasson, 2003). 
Activation of an intracellular signaling cascade culminates in mobilization of 
exocytotic cytoskeletal proteins (SNARE proteins), closure of the KATP channel, 
depolarization of the cell membrane and, ultimately, release of insulin (Nevins, 
2003). Within the brain, heart and coronary vasculature KATP channels are 
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responsible for the phenomenon of ischaemic preconditioning (Kaneko, 2005; 
Otani, 2003), whereby a preceding, sub-lethal ischaemic episode protects against 
a subsequent lethal ischaemic event. Nicorandil is a therapeutically used KCO 
that causes dilatation of coronary vessels in ischaemic heart disease (Seino and 
Miki, 2003) (Rodrigo and Standen, 2005). 
 
1.4.5 KNDP channel 
The KATP channels described in vascular smooth muscle exhibit a number of 
differences from the classical KATP channels described in other tissues. As already 
mentioned, the channel is relatively insensitive to the inhibitory effects of 
intracellular ATP [ATP]i, but is opened by NDPs including ADP, GDP and UDP 
(Matsuo et al. 2005). Given the dependence on these nucleotides not only for 
channel regulation but also for activation by KCOs, it has therefore been termed 
the KNDP channel. More fundamentally, differences are seen in the single channel 
conductance of KATP channels in smooth muscle. These can vary from 10-50 pS to 
100-250 pS, as opposed to the conductance of 70-80 pS consistently found in 
pancreatic and cardiac tissue (reviewed in (Clapp, 1998)). Typically, the KNDP 
channel is said to have a conductance of 30-40 pS (Yamada, 2000). Despite this, 
there is a great deal of evidence that the pharmacological properties of this 
channel vary significantly, depending on the smooth muscle tissue studied, with 
IC50 for ATPi varying from 350 µM in canine coronary arteries, to the millimolar 
range in porcine coronary arteries (Fujita, 2000). 
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1.4.6 KATP channels and vascular tone 
The membrane potential is determined by a number of ionic pathways. Potassium 
ions play an important role, contributing about 70% of total membrane 
conductance (Nelson et al., 1995). The normal resting membrane potential of a 
smooth muscle cell is between -50 and -70 mV. Depolarisation means shifting this 
potential in a positive direction towards the equilibrium potential for chloride 
(approximately –30 mV), whereas hyperpolarisation means shifting the membrane 
potential in a more negative direction, towards the equilibrium potential for K+ 
being approximately -83 mV in most smooth muscle types (see (Brayden, 2002) 
for review). When KATP channels close, this prevents efflux of potassium out of 
the cell, causing depolarisation of the cell membrane. The opposite occurs when 
channels open.  
 
In vascular smooth muscle, depolarisation activates voltage-dependent L-type 
calcium channels (VDCCs), leading to the influx of calcium into the cell. The 
relationship is steep around the resting potential, with a 3mV change in the 
membrane potential of a cell capable of more than doubling calcium influx 
through these channels (Nelson, 1995). Once in the cytosol, calcium can bind to 
ryanodine receptors on the sarcoplasmic reticulum (SR) causing a further release 
of calcium from the SR, a mechanism known as calcium-dependent calcium 
release. Once calcium is significantly elevated, it will activate myosin light chain 
kinase. The subsequent phosphorylation of myosin leads to actin-myosin cross-
linkage and contraction of the vascular smooth muscle cell.  
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In vascular smooth muscle, KATP channels contribute to maintenance of resting 
membrane potential and local blood flow (Nelson, 1995). Evidence that KATP 
channels are open under resting conditions comes from studies in mesenteric and 
coronary vascular beds whereby application of glibenclamide not only caused 
membrane depolarisation of between 5-9 mV (Garland, 1992), but also increased 
arterial resistance and decreased blood vessel diameter (Nelson, 1995; Salzman, 
1997). The extent to which KATP channels control blood pressure is unclear. On 
the one hand, SUR2 and Kir6.1 knockout mice are hypertensive (Miki, Suzuki et 
al. 2002; Chutkow, 2002), while there is an absence of a hypertensive effect in 
normal dogs given glibenclamide (Landry, 1992. The contribution to vascular 
tone is more evident during pathological states such as ischaemia (Thierfelder, 
1994). Low levels of intracellular ATP, indicative of the poor cellular metabolic 
status, leads to channel opening and smooth muscle relaxation. Subsequent 
dilatation of the blood vessel increases blood supply to the energy-deplete tissue 
(Salzman, 1997). The same effect is seen with hypoxia (Thierfelder, 1994) and 
with hypercapnia, whereby rising CO2 levels decrease intracellular pH, thereby 
opening KATP channels in mesenteric artery vascular smooth muscle cells (Wang, 
2003).  
 
1.4.7 Hormonal regulation of KATP channels 
Angiotensin II, vasopressin, norepinephrine and endothelin all inhibit KATP 
channel opening, and this may contribute to their vasoconstrictor mechanism 
(Miyoshi, 1991; Miyoshi, 1992; Wakatsuki, 1992; Bonev & Nelson MT, 1996). 
Such vasoconstrictors act via Gq-protein coupled receptors that can close the KATP 
channels, given that agonist effects on KATP channel currents are dependent upon 
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phospholipase C-β (PLCβ) and protein kinase C-ε (PKCε) activity (Hayabuchi, 
2001; Rodrigo and Standen 2005). 
 
In sepsis, this pathway is inhibited, either directly by nitric oxide production or 
indirectly via opening of the KATP channel. Subsequent hyperpolarisation inhibits 
opening of the voltage-dependent calcium channels and thus inhibition of 
contraction. Vasodilators such as adenosine (acting on the A2 receptor) or 
calcitonin gene-related peptide (CGRP) act via stimulatory G-protein coupled 
receptors to open KATP channels (Kleppish et al. 1995). This is a cyclic adenosine 
monophosphate (cAMP) and protein kinase A (PKA)-dependent process (see 
(Buckley, 2006), involving phosphorylation of Ser/Thr sites located on both SUR 
and Kir6.1 (Quinn et al. 2003; Quinn et al. 2004). 
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1.5 KATP channels in the pathophysiology of sepsis 
The role of KATP channel activation in sepsis can be divided into its established 
role in vascular hyporeactivity (discussed below), and its potential role in 
mitochondrial dysfunction, which is further expanded upon in the discussion 
section. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: The KATP channel may be key to several pathophysiological processes 
in sepsis, including vascular hyporeactivity, mitochondrial dysfunction and MOF . 
 
1.5.1 Vascular hyporeactivity 
Electrophysiological data show that K+ channels play a role in the control of 
vascular tone. Vascular tone refers to the degree of constriction of the vascular 
smooth muscle cells in blood vessels. In the arterial tree this is the determinant of 
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systemic vascular resistance (SVR) and, therefore, one of the determinants of 
blood pressure (BP). They are related by the equation: 
BP = SVR x CO 
where CO is cardiac output. The constriction of vascular smooth muscle is 
dependent on an increase in intracellular calcium [Ca]i in response to 
vasoconstrictors.  
 
However, the contribution of KATP channels to SVR and BP under normal 
conditions is probably minimal, as evidenced by the lack of hypertension in 
animals given glibenclamide (Landry, 1992). In the presence of pathology such as 
sepsis, hypoxia or haemorrhage, KATP channels have a more important role in the 
determination of SVR and BP (Landry, 1992; Landry, 2001 ). 
 
The evidence for the role of KATP channels in sepsis can be divided primarily into 
studies that examine their role in either short-term (<6 hrs) or longer-term 
(>20hrs) laboratory models. Only one study has formally examined their role in 
human sepsis (Warrillow et al., 2006). However, by the time a patient displays 
symptoms and signs of overt septic shock they are likely to have had systemic 
inflammation for far longer than 6 hrs. Longer-term in vivo models are likely to be 
more relevant in this regard. 
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1.5.2 In vivo models of sepsis 
The in vivo evidence for the role of KATP channels in sepsis consists of data from 
anaesthetised rats (Sorrentino, 1999; Wu, 1999), dogs (Landry, 1992) and pigs 
(Vanelli, 1995 ). Injection of LPS was found to consistently cause a drop in blood 
pressure in the animals 30-90 mins after administration (Landry, 1992; Wu, 1999) 
and was associated with vascular hyporeactivity to phenylephrine (Landry, 1992; 
Sorrentino, 1999). In most cases, both the hypotension and vascular 
hyporeactivity could be reversed by the administration of glibenclamide (Vanelli, 
1995; Landry, 1992). The beneficial effect of glibenclamide was rapid, occurring 
within a few mins and lasting for up to 20-30 mins (Landry, 1992; Vanelli, 1995). 
The effect on blood pressure was via an increase in SVR and not from an increase 
in cardiac output (Landry, 1992; Vanelli, 1995). Interestingly, hypotension caused 
by the administration of glyceryl trinitrate (GTN) or nitroprusside was unaffected 
by glibenclamide, suggesting a more complex interaction of the iNOS pathway 
with the channel (Landry, 1992). In other studies, increased vasorelaxation to the 
potassium channel opener, cromakalim, was observed in septic animals; not 
surprisingly, glibenclamide reversed this effect (Sorrentino, 1999). These in vivo 
data confirm that over-activity of KATP channels in vascular smooth muscle is 
likely to contribute to hypotension in sepsis. Indeed, a Kir6.1 knockout mouse 
displayed a blunted vasodilator response when given LPS (Kane et al. 2006).  
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1.5.3 In vitro models of sepsis 
Vascular hyporeactivity can be demonstrated in vitro using an organ bath model 
(Chen, 2000a; Chen, 2000b; Hall, 1996; O'Brien, 2001; Sorrentino, 1999; Wilson, 
2002). Here, arterial rings (with or without an intact endothelium) bathed in media 
are mounted on a spring-loaded system to maintain them under tension; a 
concentration-response curve to increasing concentrations of vasoconstrictors is 
then generated.  
 
The pathophysiological mechanisms underlying vascular hyporeactivity may 
change with time. Inhibition of NO production in in vitro models of <6 hrs’ 
duration demonstrated almost complete reversibility of hyporeactivity (Chen, 
2000; O'Brien, 2001; Sorrentino, 1999; Wilson, 2002), whereas this was only 
partial in longer-term (>20 hrs) models (O'Brien, 2001). Potential underlying 
mechanisms to explain these differences are discussed in detail later. 
 
In vitro studies can be performed in arteries extracted from septic/endotoxic 
animals, or in vessels taken from healthy animals that are subsequently incubated 
with endotoxin for varying durations (Hall, 1996; Sorrentino, 1999; Chen, 2000a; 
Chen, 2000b; O'Brien, 2001; Wilson, 2002). Decreased contractility, particularly 
to catecholamines, can be readily shown in septic/endotoxic rings as a depressed 
concentration-response curve (O'Brien, 2005). However, application of 
glibenclamide did not reverse this hyporeactivity (O'Brien, 2001). This may be 
indicative of altered channel pharmacology (Wilson & Clapp, 2002), irreversible 
damage to the contractile apparatus, or other mechanisms contributing to 
hyporeactivity.  It is equally plausible that glibenclamide fails to depolarise 
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tissues in the range that will open a significant number of voltage-gated calcium 
channels to raise intracellular calcium levels and thus increase vascular tone.  
 
In contrast, the increased ability of KATP channel openers (KCOs) to cause 
relaxation of vascular tissue in both in vitro and in vivo models of sepsis, could be 
viewed as further evidence for the role of KATP channels (Chen, 2000; 
d'Emmanuele di Villa Bianca, 2003; Sorrentino, 1999). This action can be 
exploited as another tool for examining contractility in control and septic tissues 
(Chen, 2000a; Chen, 2000b; Wilson, 2002). From a mechanistic standpoint it 
suggests that during sepsis the KATP channel is in a state more favourable to 
opening. A more stable binding of Mg2+ADP to the nuclear binding folds on the 
cytosolic surface of the SUR protein would facilitate this type of interaction. 
Similarly, the SUR protein favouring the “open” conformation would have the 
same effect on channel function and characteristics.  
 
The use of ex vivo models also enables the simultaneous assessment of membrane 
electrophysiology, enabling demonstration of membrane hyperpolarisation during 
vascular hyporeactivity (Chen, 2000; Wu et al., 2004).  Using a 6 hour in vivo 
model, Chen et al demonstrated that LPS given intravenously to anaesthetised 
Wistar-Kyoto rats caused hypotension and vascular hyporeactivity to 
norepinephrine. Subsequent ex vivo studies demonstrated LPS-induced 
hyporeactivity in an organ bath model, and hyperpolarization measured using 
microelectrodes. This hyperpolarization was reversed using inhibitors of NO 
synthase (L-NAME) and partially reversed by glibenclamide, confirming a role of 
KATP channels.  
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1.6 Factors that might contribute to KATP channel opening 
 
1.6.1 Nitric oxide and KATP channels in sepsis 
Overwhelming evidence from animal models suggests that endotoxin-induced 
hypotension and vascular hyporeactivity is largely a consequence of over-
production of iNOS-derived NO within the blood vessel wall (Thiemermann, 
1994; Thiemermann, 1997). Increased production of NO, albeit at much lower 
levels, is recognised in patients with sepsis (Ochoa, 1991) and inversely correlates 
with mean arterial pressure and systemic vascular resistance (Bellissant, 2000 ).  
 
Compared to animals, induction of iNOS appears restricted in humans, occurring 
mainly in blood vessels at the point of infection (Bellissant, 2000) or in 
infiltrating monocytes (Kobayashi, 1998). Taken together, this may suggest that 
NO derived from iNOS may not be the only source of NO in human sepsis 
(Vallance, 2001). However, iNOS may be present at levels below the limit of 
detection but still produced in sufficient quantity to have a significant effect on 
vascular tone in humans. In addition, although specific iNOS inhibitors have not 
been used in human sepsis, the use of non-specific NOS inhibitors resulted in 
potent elevation of BP (Petros, 1994).  
Once formed, NO can activate soluble guanylate cyclase and increase cyclic 
GMP, or it can react with superoxide to form peroxynitrite (ONOO-), a process 
that occurs more readily during systemic inflammation (Frost, 2005).  
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As previously mentioned, the NO/cyclic GMP pathway is likely to be responsible 
for KATP channel activation, at least in the short term (<6 hr) (O'Brien, 2001). 
NOS or guanylate cyclase inhibitors fully reversed endotoxin-induced 
hyporeactivity or membrane hyperpolarisation with effects of near-similar 
magnitude to that seen with KATP channel blockade (Hall, 1996; O'Brien, 2001; 
O'Brien, 2005; Wilson, 2002; Wu, 2004). NO can also potentiate KCO responses 
in cardiac myocytes (Shinbo, 1997). In septic models, potentiation of 
levcromakalim-induced hypotension or vascular relaxation can be largely 
reversed by NOS or guanylate cyclase inhibition (Chen, 2000; Sorrentino, 1999; 
Wilson, 2002).  
  
 
1.6.2 Calcitonin Gene-Related Peptide and KATP channels in sepsis 
Calcitonin gene-related peptide is a 37 amino acid vasoactive peptide contained in 
sensory neurones that plays a role in the regulation of local blood flow. It is a 
potent vasodilator. Increased levels of CGRP were reported in septic rats (Griffin, 
1992), and administration of a CGRP receptor antagonist (hCGRP) transiently 
reversed tachycardia and hypotension (Huttemeier, 1993). In normal blood 
vessels, glibenclamide partially reversed the relaxation of mesenteric arteries 
when exposed to CGRP (Nelson, 1990). CGRP is thought to activate KATP 
channels via increased levels of cyclic AMP and subsequent activation of protein 
kinase A (PKA) (Quayle, 1994). 
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1.6.3 The actin cytoskeleton: not just scaffolding for KATP channels? 
The actin cytoskeleton consists of the protein actin (molecular mass 42kDa), 
which represents 50% of total cellular protein content. It exists in α, β and γ 
isoforms, with the functional polymerised form (F actin) consisting of many 
monomers of globular (G actin) (Janmey, 1998). These are in a dynamic (Amann, 
2000; Gokina, 2002), energy-dependent flux which is controlled by, amongst 
other things, small GTP proteins e.g. Rho kinases (Peck, 2002). The cytoskeleton 
plays a role not just as a scaffolding protein determining the shape of the cell, but 
also in cell division, cell motility, contraction (e.g. cardiac, skeletal & smooth 
muscle cells), as well as being implicated in the control of various ion channels. 
For example, disruption of the cytoskeleton increased Na+ influx via Na+ channels 
in the jejunum (Strege, 2003) and increased chloride efflux via Cl- channels in 
renal cortical cells (Schwiebert, 1994). The cytoskeleton is also implicated in the 
trafficking of proteins from the nucleus to the cell membrane, and signal 
transduction from the membrane to the nucleus, including nuclear transcription 
induced by shear stress in endothelial cells (Numaguchi, 1999). 
 
Interactions between the actin cytoskeleton and the KATP channel have mainly 
been shown in isolated cardiac myocytes (Brady, 1996; Terzic, 1996; Yokoshiki, 
1997), vascular smooth muscle cells (Loffler-Walz, 1998) and other artificial cell 
lines. Disruption of the cytoskeleton with the fungal toxin cytochalasin D (Terzic, 
1996), or with DNAse I (Brady, 1996) causes increased opening of the KATP 
channel. Such effects were accompanied by altered glibenclamide binding 
(Yokoshiki, 1997) and decreased efficacy of other closers of the channel (Brady, 
1996; Yokoshiki, 1997).  
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Nitric oxide disrupts the actin cytoskeleton in various cell types, including the 
lamina propia of the small intestine (Banan, 2000; Chakravortty, 2000), the 
kidney (Sandau, 2001) and in liver and kidney tissue in a murine model of sickle 
cell disease (Aslan, 2003). This is likely to be secondary to nitration (Aslan, 2003; 
Banan, 2000) or nitrosylation (Dalle-Donne, 2000) of actin. In addition, 
disruption of the actin cytoskeleton secondary to LPS has been shown in bovine 
aorta endothelial cells (Chakravortty, 2000) and in pulmonary vascular 
endothelial cells (Goldblum, 1993). 
 
Alternatively, this phenomenon of the cytoskeleton altering KATP channel activity 
may be a result of changes in the energy status of the cell. This may therefore be a 
phenomenon seen alongside increased KATP opening during ATP-deficient states. 
However, it is also possible that the cytoskeleton is required for the KATP channel 
to execute its conformational change from the open to the closed state, and that 
disruption of the cytoskeleton in sepsis inhibits this conformational change. This 
situation would then keep the KATP channel open, thus causing relaxation of the 
relevant muscle. Disruption of the actin cytoskeleton has a direct effect on the 
contractile apparatus of muscle cells; if this were the sole consequence of such 
disruption it may be sufficient to cause vascular hyporeactivity in sepsis. 
Furthermore, the increased protein turnover and decreased synthesis seen for 
many proteins during sepsis may also underlie any alteration in cytoskeletal 
function. Ultimately, the disruption of the cytoskeleton is likely to have an 
irreversible effect on vascular hyporeactivity in longer-term models of sepsis. 
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1.6.4 Changes in energy status in sepsis 
KATP channels may be opened by a fall in [ATP]i, pH or oxygen tension, or by a 
rise in intracellular lactate and NDPs (Clapp, 1998; Landry, 2001). These may 
facilitate NO activation of the channel or act independently. Many of these factors 
operate in sepsis though the extent to which these play a role will likely depend on 
the degree of perturbation of the individual variable, as well as the severity and 
duration of the septic insult. Lactic acidosis is consistently reported in animal and 
human sepsis (Landry, 1992; Fall, 2005; Revelly, 2005) although, paradoxically, 
tissue hypoxia is not found in the resuscitated patient/animal, with raised tissue 
oxygen tensions reported in skeletal muscle (Boekstegers, 1991), bladder 
epithelium (Rosser, 1996) and gut mucosa (VanderMeer, 1995). This finding, in 
conjunction with a decrease in global oxygen consumption, suggests adequate 
availability but decreased cellular utilisation of oxygen, giving rise to a state of 
‘cytopathic dysoxia’ related to mitochondrial dysfunction, increased generation of 
NO and decreased production of ATP (Boveris, 2002; Brealey, 2004). The 
ensuing ‘energy failure’ is implicated in the pathophysiology of organ failure. Of 
note, ATP levels are preserved in the skeletal muscle of eventual survivors of 
septic shock but fall in non-surviving patients (Brealey, 2002). This fall in ATP 
with increasing sepsis severity has been replicated in other tissues in various 
animal models (Brealey, 2004; Hart, 2003). Thus, opening of KATP channels due 
to metabolic failure may only be significant in severe sepsis. In vascular smooth 
muscle, this is likely to depend to a greater extent on the change in NDP levels 
rather than on ATP itself because of the main subtype (Kir6.1/SUR2B) expressed 
in this tissue (Kantrow, 1997). 
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1.6.5 Altered KATP channel expression in sepsis 
Increased expression of KATP channels may contribute to channel activation and 
vascular hyporeactivity in sepsis. Simultaneous administration of dexamethasone 
and LPS to rats completely abolished the hyporeactivity to phenylephrine 
observed after 24 hrs from LPS injection alone (d'Emmanuele di Villa Bianca, 
2003). Dexamethasone treatment also significantly reduced, in a time-dependent 
manner, the increased hypotensive effect induced by cromokalim in LPS-treated 
rats. This effect was significantly reverted by the glucocorticoid receptor 
antagonist RU38486 (6.6 mg/kg i.p.). Glibenclamide-induced hypertension in 
LPS-treated rats was significantly inhibited by dexamethasone, if administered at 
the same time of LPS. (d'Emmanuele di Villa Bianca, 2003). Thus, the KATP 
channels were no longer activated (opened) by sepsis and therefore attempted 
closure by glibenclamide had no effect. This is akin to the effect of administering 
glibenclamide to normal, non-septic animals. Dexamethasone could also inhibit 
de novo KATP channel protein synthesis, which could also be involved in its effect. 
This suggests that the beneficial effect of corticosteroids in improving vascular 
tone in sepsis could be ascribed, at least in part, to its ability to interfere with KATP 
channel activation.  
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Figure 1.4: Mechanisms involved in vascular smooth muscle contraction (in red) 
and relaxation (in green). A2: adenosine receptor, α1: alpha-1 adrenoceptor, V1: 
vasopressin receptor, CGRP: calcitonin gene-related peptide, Gi/Gs: inhibitory/ 
stimulatory G-protein coupled receptors, NFκB: nuclear transcription factor kappa 
B, NO: nitric oxide, ONOO•-: peroxynitrite, ROS: reactive oxygen species, PLC-
β: phospholipase C β, PKC: protein kinase C.  
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1.7 Role of BKCa channels in sepsis 
 
1.7.1 Vascular hyporeactivity 
BKCa channels are found in the membranes of most cell types and are abundantly 
expressed in vascular smooth muscle cells (Nelson, 1995). BKCa channels, like 
KATP channels, alter the electrophysiological state of the membrane of vascular 
smooth muscle cells, regulating calcium entry into the cell and hence altering 
vessel wall tone (Nelson, 1995). NO directly activates BKCa channels in normal 
vessels (Mistry, 1998) and septic vessels. NO produced through iNOS can open 
BKCa channels (Miyoshi, 1994; Nameda, 1996), contributing to membrane 
hyperpolarisation induced by LPS in rat thoracic aorta (Chen, 2000a; Chen, 
2000b). Conceivably, BKCa and KATP channels may work in concert in sepsis to 
produce changes in vascular reactivity.   
 
1.7.2 Regulation of immune function 
Circulating neutrophils play a pivotal role in the killing of a range of pathogens. 
In human neutrophils, microbial killing was elicited by BKCa channel activation. 
This functions to provide the K+-rich environment necessary for activation of 
proteases within the phagocytic vacuole (Ahluwalia, 2004). In macrophages, 
endotoxin-induced cytokine release, particularly that of TNF-α, Il-6 and 
interferon-γ, requires prior K+ channel activation. This involves a number of 
different types, including BKCa, inward rectifier and Kv channels (Haslberger, 
1992; Blunck, 2001; Muller, 2003). Production of NO by activated macrophages 
is also an important cytotoxic function involved in the killing of micro organisms. 
Both KV and KATP channels promote cytokine-induced NO production (Wu, 1995; 
Introduction 
 54 
Lowry, 1998). Taken together, K+ channels appear to be key players in the early 
activation of immune cells. 
 
1.8 Cellular metabolism  
The KATP channel links the metabolic state of the cell to its membrane potential; 
in VSMCs this channel influences contractile state and hence vascular tone. Like 
all cells in the body, vascular smooth muscle cells utilise ATP as an energy 
substrate. Energy is derived from hydrolysis of the high-energy phosphate bonds 
within ATP. Hydrolysis of ATP to ADP + Pi and ADP to AMP + Pi yields 30.5 Kj 
mol-1 per phosphate bond hydrolysed. This ATP is derived from glucose, free fatty 
acids and protein through glycolysis, β oxidation, oxidative phosphorylation and 
the phosphocreatine-phosphate transfer system. ATP and ADP levels are 
important for control of cellular metabolism (operating with negative feedback 
loops), and for control of the KATP channel. Therefore, understanding cellular 
metabolism helps in understanding the potential effects of sepsis on ATP and 
ADP levels and, hence, on KATP channel function.  
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Figure 1.5: The KATP channel consists of two proteins, an ion-channel pore and a 
sulphonylurea receptor subunit (SUR). These interact at their N- and C- termini, 
respectively. On the left is a representation of the two subunits of the KATP 
channel under normal circumstances and, on the right, the KATP channel in sepsis 
where it is abnormally open in vascular smooth muscle cells. The diagram 
illustrates the various hypotheses as to underlying mechanisms. These include 
abnormal regulation of the channel by the sulphonylurea receptor subunit, altered 
binding of inhibitors of the channel and metabolic disregulation. The altered 
control of the pore by the SUR may be caused by disruption of the cytoskeleton or 
by nitration and/or nitrosylation of the proteins involved. 
 
ATP: adenosine triphosphate, Mg2+ADP: magnesium adenosine diphosphate, 
NBF-1 and NBF-2, nucleotide binding folds -1 and -2 respectively. Glib: 
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Hypothesis: 
During sepsis we observe vascular hyporeactivity due to altered function and 
subsequent opening of the KATP channel. It is hypothesised that the reasons for 
this channel opening are due to a combination of/one of the following effects: 
a) Disruption of the actin cytoskeleton. The actin cytoskeleton has been 
shown to interact with the KATP channel (Brady, 1996; Terzic, 1996; 
Yokoshiki, 1997, Loffler-Walz, 1998). Disruption of F actin into G actin 
induces opening of the KATP channel (Brady, 1996; Terzic, 1996). Such 
effects were accompanied by altered glibenclamide binding (Yokoshiki, 
1997) and decreased efficacy of other closers of the channel (Brady, 1996; 
Yokoshiki, 1997). This altered pharmacology is similar to that seen in 
sepsis (Wilson & Clapp, 2002; O’Brien et al., 2005). I hypothesised that 
this increased KATP channel opening and altered pharmacology in sepsis 
was due to disruption of F actin into G actin. 
b) A direct NO effect. The role of NO in endotoxin-induced vascular 
reactivity is well established (Thiemermann & Vane, 1990) and this has 
been demonstrated to be due to KATP channel opening, via a cGMP 
pathway (O'Brien, 2001; O'Brien, 2005; Wilson, 2002). NO also causes 
disruption of the actin cytoskeleton (Banan, 2000; Chakravortty, 2000; 
Sandau, 2001; Aslan, 2003). I hypothesised that NO caused altered 
pharmacology via a direct NO effect on the channel. 
c) Metabolic derangement. KATP channels are inhibited by intracellular ATP 
(Yamada, 2000; Fujita, 2000) and opened by intracellular NDP. Metabolic 
derangement, with altered ATP levels, has been demonstrated in sepsis 
(Brealey et al., 2002; Brealey et al., 2004). I hypothesised that altered 
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levels of ATP and ADP in rat thoracic aorta caused increased opening and 
altered pharmacology of KATP channels in sepsis.  
 
 
Aims of Study: 
1). To develop a technique for semi-quantifying the actin-cytoskeleton in rat aorta 
and mesenteric artery vascular smooth muscle using confocal microscopy and 
immunohistochemistry. 
2). To semi-quantify levels of F and G actin in vascular smooth muscle using 
Western blotting techniques. 
3). To assess the effects of sepsis on the actin cytoskeleton using an in vitro model 
of endotoxin incubation. 
4). To compare results in 3) against those with a NO donor. 
5). To assess parallel effects upon KATP channel function using specific activators 
and inhibitors of the sulphonylurea receptor and ion channel pore subunits. 
6). To measure ATP, ADP & AMP levels in thoracic aorta taken from an in vivo 
model. 
All work complied with the Animals (Scientific Procedures) Act 1986 and the 
Home Office Project License that gave authority for the work. 
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2.1 Animal dissection 
For the in vitro model of sepsis, rings of aorta and mesenteric artery were 
obtained from male Sprague Dawley rats (200-300g, Charles River, UK) 
sacrificed according to Schedule 1 of the Animals (Scientific Procedures) Act 
1986 and the Home Office License for this project. The animals were stunned 
with a blow to the head and sacrificed via cervical dislocation. The abdomen was 
then opened, the retroperitoneal cavity identified and then opened. Following 
identification of the superior mesenteric artery, the superior portion of the 
mesentery was carefully dissected and a length of it was then removed from its 
origin at the aorta to its distal portion. The abdominal aorta was then identified, 
and dissected free from the vertebrae, starting distally at the bifurcation of the 
iliac arteries and proximally to the diaphragm.  
 
Each of the vessels was then placed in physiological salt solution (PSS) 
containing in mM: NaCl 112, KCl 5, MgCl2 1, NaHCO3 25, NaH2PO4 0.5, 
KH2PO4 0.5, glucose 10, CaCl2 1.8. The vessels were then further cleaned and cut 
into rings, 3-4 mm in length. These rings were then washed twice in sterile 
Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, Paisley, UK) 
containing penicillin/streptomycin (pen/strep, 50 U.ml-1/50 µg.ml-1 respectively).  
 
2.2 In vitro model of sepsis 
Rings of aorta or mesenteric artery were incubated for 24 hr or 48 hr in 2 ml of 
DMEM containing 0.1µg/ml LPS (Salmonella typhosa, Sigma-Aldrich, Dorset, 
UK) and pen/strep at 37oC, in a humidified atmosphere of 5% CO2. Control tissue 
was incubated in DMEM alone. The addition of pen/strep was required because 
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initial experiments showed there was a significant degree of hyporeactivity in all 
control tissue at 48 hr when antibiotics were not added to the culture medium 
(data not included). The concentration of LPS used was based on pilot data based 
on previous studies done by Wilson et al. (Wilson et al., 2000) and O’Brien et al. 
(O’Brien et al., 2001). 
 
2.3 In vivo model of sepsis 
The established conscious in vivo model of faecal peritonitis previously published 
by our laboratory (Brealey, 2004) was used. Raymond Stidwell and Valerie 
Taylor carried out this model. Male Wistar rats at 14 weeks old (approx 300-
350g) were anaesthetised with inhaled isoflurane. A midline incision was made 
over the anterior chest wall and catheters were inserted into the carotid artery and 
external jugular vein. These lines were then tunnelled beneath the skin and exited 
the rat over the back of the animal. This was then connected to a mobile, pivoted 
tether (fig.2.1). The rat was allowed to recover from surgery and anaesthesia for 
24 hr.  
 
The rat was then fluid resuscitated at a rate of 10 ml.kg-1.hr-1 using a mixture of 
0.9 % saline and 5% dextrose, in a 1:1 ratio. Animals assigned to the septic group 
were then injected with a solution of faeces (0.625 ml/ 100g body weight) 
obtained from another male Wistar rat (Brealey et al., 2004). Time of injection 
was assigned “Time 0”. The animal continued to have free access to food and 
water for the duration of the experiment. The rats were then sacrificed at either 24 
hr or 48 hr time points. Appropriate controls were animals that underwent the 
same surgical procedure, but were not injected with faeces. Before death at 
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predetermined time points, rats were scored as having mild, moderate, or severe 
sepsis. The scoring assessed appearance, alertness, and blood pressure (Brealey et 
al., 2004). Mildly affected animals were hunched, alert, displayed piloerection, 
with a blood > 90 mmHg. Moderately affected animals were hunched, with 
marked piloerection, a bloated abdomen, sunken eyes, depressed level of 
alertness, decreased mobility and a lower blood pressure of 75 – 90 mmHg. 
Animals with severe sepsis had marked piloerection, a markedly bloated 
abdomen, depressed level of consciousness, no movement and a significant drop 
in blood pressure, < 75 mmHg (see Brealey et al., (2004)) for a more detailed 
description. 
 
Tissue was then removed under deep anaesthesia at either 24 hr or 48 hr time 
points. For measurement of ATP, ADP and AMP levels thoracic aorta was 
removed and immediately frozen in liquid nitrogen. This was then processed as 
described below. Abdominal aorta was removed for functional organ bath studies 
and placed in HBSS. 
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Fig. 2.1. A: Photograph of surgical insertion of venous line into the left external 
jugular vein in a male Wistar rat. The animal is deeply anaesthetised using inhaled 
isoflurane. B: Photograph of a male Wistar rat recovering from surgery, with the 
tunnelled lines exiting from the animals back. The lines are tethered to a pivoted 
arm above the cage, allowing the animal to move freely within its cage.  
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2.4 Organ bath Studies 
Measurement of isometric tension in rat mesenteric artery and aortic rings was 
achieved using the classical organ bath method. Intact rings of artery were 
suspended between two tungsten wires in a jacketed organ bath (25 ml volume) 
containing physiological salt solution, maintained at 37 0C, gassed with 95% O2 / 
5% CO2. One of the wires was fixed to an external platform; the other was 
connected to an isometric force displacement transducer (FT-03, Grass 
Instruments, Astro-Med UK, Slough, UK) for measurement of tension. Tension 
was recorded using Powerlab Chart (version 4), a data acquisition and analysis 
program for biological systems (ADInstruments, Oxfordshire, UK). The aorta 
from a single animal was cut into eight rings and set up in 8 individual organ 
baths. The rings were maintained at a resting tension of 1g and equilibrated for 
one hour.  
 
2.4.1 Endothelium intact experiments 
Phenylephrine (PE, 1 µM) was used to contract the tissue (O’Brien & Wilson, 
2001). Once the contraction had reached a plateau, acetylcholine (5 µM) was 
added and only those tissues showing relaxation > 50%, was endothelium 
considered functional (O’Brien & Wilson, 2001). After wash off of acetycholine, 
the tissue was further primed by the addition of KCl (50 mmol) and following 
several washes, tissues were further contacted with 1 µM PE. This was again 
washed off before the main experiments were carried out (O’Brien & Wilson, 
2001). 
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Fig 2.2: Schematic of a vessel (A) divided into rings, which were then mounted in 
the organ bath (B), where tension studies were carried out at 37oC in 
physiological salt solution (Krebs’). (C) A sample trace from a cumulative 
concentration-response curve to PE in a ring of mesenteric artery. The arrows 
indicate the time when each concentration of PE (10-9-10-5 M) was added to the 
bath. 
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2.4.2 Functional assessment of blood vessels used in microscopy  
Rings from the same vessels that were used in immunohistochemistry and 
confocal microscopy were examined in the organ bath. The tissue was set up and 
primed as described above and all experiments were performed in vessels where 
the endothelium remained intact. PE concentration-response curves were carried 
out (10-9 – 10-5 M) on fresh tissue and tissue from the 24 hr and 48 hr time points 
(± LPS, 1 µg.ml-1) (O’Brien & Wilson, 2001). Therefore, the images obtained 
could be matched with known contractile responses in normal tissue (fresh tissue 
and 24 hr and 48 hr time controls) or from hyporeactive tissue (LPS treatment for 
24 and 48 hr). 
 
2.4.3 KATP channel pharmacology in an in vitro model of sepsis 
Tissue obtained from the in vitro organ culture model of sepsis was placed in the 
organ bath, primed as described above, and then contracted with 1 µM PE. Once 
contractions had peaked, the KATP channel opener, levcromakalim (3 µM) was 
applied and when relaxation had reached a plateau, either PNU 37883A (10 µM) 
or glibenclamide (10 µM) were added to the organ bath (O’Brien & Wilson, 
2001). Results were then displayed as percentage reversal of levcromakalim-
induced relaxation. Concentrations of drugs used were based on pilot data (data 
not shown) and on previous studies done by Wilson et al. (Wilson et al., 2000) 
and O’Brien et al. (O’Brien et al., 2001). 
 
2.4.4 Assessment of effects of Deta NO on KATP channel pharmacology 
To investigate the direct effects of NO on the KATP channel, an NO donor (Deta 
NO) was used to replicate levels measured in an in vitro model of sepsis (O’Brien 
Materials and Methods 
 66 
et al., 2002). Tissue was incubated in DMEM (Invitrogen, Paisley, UK) with 10 
µM Deta NO (Sigma Aldrich, Dorset, UK) for 20 hr. This concentration and time 
point was based on a calculation of the half-life of Deta NO at room temperature 
and pH 7.4 to be ~20 hr (Griffiths & Garthwaite, 2001) (fig.2.2). Previous data 
(O’Brien et al., 2002) suggested that the level of nitrite produced in the 
supernatant of a ring incubated with LPS for 20hr was 2 µM per mg of protein. 
Therefore, this was the desired level of nitrite in DMEM, reflecting the amount of 
NO that blood vessels would have been exposed to in organ culture with LPS. 
Levcromakalim (10-9 – 10-5 M) (O’Brien & Wilson, 2001) concentration-response 
curves were then carried out on abdominal aorta incubated for 20 hr in DMEM ± 
Deta NO (10 µM) to explore KATP channel pharmacology after exposure to a pure 
NO donor. 
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Fig 2.3: Theoretical decay curves for Deta NO, 37 oC, pH 7.4. At the 20 hr 
time point, an initial concentration of 10 µM Deta NO will break down by 50%, 
i.e. 5 µM. One mole of Deta NO releases 2 moles of NO. Therefore, the 
breakdown of 5 µmoles of Deta NO will release around 10 µmoles of NO. 
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2.4.5 KATP channel pharmacology in an ex vivo model of sepsis  
Abdominal aorta from the male Wistar rats subjected to faecal peritonitis for 0, 24 
and 48 hr were dissected out and placed in the organ bath and subjected to 
protocols as described in 2.4.1 above. Concentration-response curves were 
generated to PE and levcromakalim (10-9 – 10-5 M) to assess whether the tissue 
exhibited typical pharmacology seen in septic tissues (O’Brien et al., 2002).  
 
2.5 Immunostaining of frozen sections 
My hypothesis states that sepsis decreases the polymerised (F) actin and may 
either increase or have no effect on the monomeric/dimeric (G) α actin. 
Immunohistochemistry was used to stain for F and G actin in abdominal aorta and 
mesenteric artery taken from male Sprague Dawley rats (250-300g, Charles 
Rivers, UK). These rings were placed in OTC embedding medium (Sakura, 
Berkshire, UK), snap frozen in liquid nitrogen and then cut at -20oC into 10 µm 
transverse sections using a cryotome (Model AS 620 SME, Thermo Shandon, 
Cheshire, UK). Sections were then placed on polysine-coated slides (BDH 
Laboratories, Poole, UK) and allowed to air-dry for 45 minutes. Following this, 
sections were outlined using a PAP Pentomark pen to provide a waterproof barrier 
for the immunostaining. These sections were then rehydrated in phosphate 
buffered saline (PBS) containing 0.02% bovine serum albumin (BSA) solution for 
three minutes. Subsequently they were permeabilised with PBS + 0.2% Triton X-
100 for three minutes, followed by two successive 2 minute washes with PBS 
containing 0.02% BSA. So as to inhibit non-specific protein binding, the section 
was blocked with serum-free protein block (DAKO, California, USA) for 30 
minutes. The surplus fluid was drained off (not washed) and either AlexaFluor 
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568 Phalloidin (1:40 dilution; 20 µl per section) or Texas Red-labeled DNAse I 
(20 µl per section) was applied to the sections and incubated for 45 minutes. 
Antibody concentrations were developed from pilot data (not shown). Following 
this, three successive 2 minute washes were carried out with PBS + 0.02% BSA. 
Finally, the sections were fixed using 5% formal-saline for five minutes, before 
being washed with distilled water and air-dried for 45 minutes. Once dried, a drop 
of Vectashield (Vector Laboratories, California, USA) was applied and a cover 
slip placed on the slide. This was then sealed using nail varnish. 
 
2.6 Confocal microscopy 
Confocal microscopy was used with a view to assess changes in the actin 
cytoskeleton using an image quantification method. This presented a number of 
methodological challenges. The majority of confocal imaging is performed on 
cells rather than tissue. In addition, confocal microscopy is normally utilised in a 
semi-quantitative fashion and my aim was to develop a reproducible, quantitative 
method of obtaining and analysing confocal images. Images were taken from 
transverse sections of aorta to determine the optimum laser and confocal settings 
to quantify both F and G actin. An initial problem was how to focus on tissue 
sections, and from which area of this tissue should one obtain images in a non-
biased fashion. Focusing on the elastin layer of vessels solved this, which 
autofluoresces in the green spectrum (488 nm), most likely to be due to the 
presence of several fluorescent compounds, including a cross-linking tricarboxylic 
amino acid with a pyridinium ring (Deyl et al., 1980). Focusing on the elastin also 
helped to delineate the boundaries of the image. The initial experimental design 
had been to image F and G actin simultaneously in the same sections. However, 
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the majority of the commercially available actin flurophores emit light in the 
green (488nm) and red (568nm) spectra. Since elastin autofluorescence precludes 
the use of fluorophores emitting in the green spectrum, I was forced to look at F 
and G actin in separate sections because it was not possible to separate out signals 
from probes emitting in the red spectra.  
 
Alexa Fluor-568 Phalloidin (Molecular Probes, Amsterdam, Europe) was used to 
stain for F actin. 20 µl of a 1:5 dilution of the fluorophore was used per section of 
tissue (concentration developed from pilot data, not shown). This was then 
stimulated using a green Helium/Neon laser at 543 nm. A long pass filter was set 
at 560 nm, with a short pass filter at 570/590 and all emission above this was 
captured. Images were obtained (x60 magnification with a water immersion lens) 
via a confocal microscope (Bio-Rad Radiance 2100) using Lasersharp 2000 image 
acquisition software (Bio-Rad, Hemel Hempstead, UK) and staining quantified 
using Laserpix software (Bio-Rad, Hemel Hempstead, UK). G actin was 
identified using Texas Red- labelled DNAse I (Molecular Probes, Amsterdam, 
Europe) with 20 µl of a 10 mg/ml stock used per tissue section and incubated for 
45 min at room temperature (concentration developed from pilot data, not shown). 
The slides were then stimulated using the green Helium/Neon laser, using the 
same wavelengths and filters as above.  
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Fig 2.4: Light pathways used in confocal microscopy (Biorad). Only focused light 
is seen by the photomultiplier detector, as opposed to other microscopes, which 
allow unfocused light through. This enables tissue sections to be examined in 
steps of 1 µm thickness at a time if desired. 
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2.7 Tissue homogenisation and alpha actin separation 
Biochemical quantification of the levels of F and G actin was carried out 
according to the detailed method previously published (Hall et al., 2000). Briefly, 
the abdominal aortae from male Sprague Dawley rats were weighed, then finely 
chopped and placed in 10 ml of extraction buffer (100mM KCl, 2mM EGTA, 
1mM MgCl2, 0.5% Triton-X 100), which also contained one protease inhibitor 
tablets, (Complete mini, EDTA-free, Roche, UK). Phalloidin (10µg.ml-1) (Sigma, 
Dorset, UK) was added to the cold (4 oC) extraction buffer and allowed to 
permeate the chopped tissue in order to stabilise the F actin content of the vessel 
thereby inhibiting seepage into the extraction buffer (Hall et al., 2000). This 
sample was not homogenised, but allowed to sit in the phalloidin-containing 
buffer on ice. The supernatant, assumed to contain some F but mainly G actin, 
was decanted after a 4 hr incubation and spun at 350,000g at 4oC at for 90 
minutes. Following centrifugation, the secondary supernatant was removed and 
assumed to only contain G actin (Hall et al., 2000). The remaining chopped tissue, 
post decanting of the supernatant, was blotted dry, weighed and placed in further 
extraction buffer (20 µl of buffer per mg of tissue) before being homogenised in a 
glass mini-homogeniser (Kontes, New Jersey, USA). This sample was taken to 
represent total F actin in the tissue sample. It was assumed that all G actin was 
extracted from the tissue, while all F actin was stabilised within the tissue during 
the 4hr incubation period. See fig. 2.5 for a summary of this method. Filamentous 
(F) actin consists of polymerised monomeric (G) actin, has a greater mass and can 
therefore be separated by centrifugation. 
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The final method used for separating F and G actin had an additional step of 
centrifuging the homogenised sample (theoretically F only) at 260,000g for one 
hour at 4 oC (fig.2.5). This step was added because the positive controls contained 
not just F actin in this sample, but additional G actin, indicating insufficient 
separation of F and G prior to homogenisation. Therefore, the additional 
centrifugation step was used to remove this contamination of the F actin pellet by 
G actin (see results section). 
 
2.8 Western Blotting 
Protein samples (normalised to volume) were run on an SDS-Page gel. This 
consisted of a resolving gel (7.5% acrylamide, 1.5 M Tris base, 10% SDS, 10% 
ammonium persulphate (APS), TEMED, pH 6.8) and a stacking gel (5.36% 
acrylamide, 1.0 M Tris base, 10% SDS, 10% APS, TEMED, pH 8.8). The gels 
were run on ice, at 200 V, for one hour in high-salt running buffer (SDS 3.5 mM, 
Tris base 24.8 mM, glycine 193 mM). These gels were then cold-transferred 
electrophoretically to nitrocellulose membranes (Hybond, Amersham 
Biosciences, Buckinghamshire, UK) at 4oC for 3 hours, in transfer buffer (SDS 
1.3 mM, Tris base 48 mM, glycine 39 mM, methanol (20% v/v)). Blots were then 
blocked overnight with blocking buffer (PBS, 0.1% Tween, 400 µg I-Block 
(Tropix, MA, USA)), washed with PBS, and stained with mouse monoclonal 
antibody (1:50,000 in blocking buffer) to α actin (mouse monoclonal anti-actin, 
alpha smooth muscle; Sigma-Aldrich, Dorset, UK) for one hour (antibody 
concentration developed from pilot data, not shown). These were then washed 
four times with washing buffer (PBS, 0.1% Tween) for 15 minutes each. 
Secondary anti-mouse antibodies, at a 1:5000 dilution (peroxidase-labelled, 
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Amersham Biosciences, Buckinghamshire, UK) were then applied for one hour. 
This was again washed with washing buffer, as above. All antibodies were 
dissolved in blocking buffer. The gels were stained using the ECL Western 
Blotting chemiluminescence immunoblot detection system (Amersham 
Biosciences, Buckinghamshire, UK). These were then exposed to Hybond ECL 
photosensitive films (Amersham Biosciences, Buckinghamshire, UK) and then 
developed. Typical exposure times were from 5 secs to 1 min 30 secs. 
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Fig 2.5: Separation of F & G Actin: Schema demonstrating the method for 
separating F and G actin, as per protocol published by Hall et al (2000) (Hall et 
al., 2000). The vessel is finely chopped and incubated in phalloidin for 4 hr. The 
supernatant is then decanted; this represents F and G actin. G is further extracted 
by centrifugation. The finely chopped vessel is then homogenised, representing 
the F actin fraction. 
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2.9 Griess Assay 
The Griess assay is a method for the quantification of nitrite (NO2-) in a variety of 
solutions, including cell culture media. NO is unstable therefore NO2- is used as a 
marker of its production. The Griess reaction is based on a diazotisation reaction, 
with the production of a coloured azo compound. This is concentration-dependent 
and hence colorimetric measurement of the azo compound allows quantification 
of nitrite, which is then used as a surrogate marker for NO production. 
 
Nitrite measurements were carried out on culture media using the Griess assay 
(Alexis Corporation, Nottingham, UK) (method as per O’Brien & Wilson, 2001). 
Briefly, 100 µl of media was placed in a 96 well plate. 50 µl of Griess assay 
solution 1 (0.1% naphthylethylenediamine dihydrochloride in distilled water) was 
added, with 50 µl of Griess assay solution 2 (1% sulfanilic acid in 5% 
concentrated H3PO4). This was carried out in triplicate, with an appropriate series 
of standards (1 µM- 100 µM) produced by the serial dilution of sodium nitrite 
solution (fig.2.6). The samples were mixed on a rotating plate and left for 15 
mins. The plate was then placed in a spectrophotometer (Opsys MR, Dynex 
Technologies, Worthing, UK) and absorbance measured at 540 nm. 
 
Deta NO was used as a direct NO donor to assess the effects of NO on the 
pharmacology of the KATP channel. For the Deta NO experiments, 10 µM Deta 
NO was dissolved in DMEM and rings of endothelium-intact rat aorta were 
placed in 2 ml of media in 6 well plates for 20 hr. After this time period, the 
supernatant was then taken and analyzed as described above. 
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Nitrite quantification was also carried out on the supernatant from tissues used in 
the in vitro organ culture model of sepsis. The aim was to quantify nitrite levels 
produced by that model, thus validating 10 µM Deta NO as producing a similar 
amount of NO. This is demonstrated in fig.3.10. 
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Fig 2.6: Example standard curve of nitrite concentration against absorbance at 
540 nm, mean ± SEM, samples are in triplicate. 
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2.10 Protein assay 
Protein assays were carried out using the Lowry Method, with the BioRad DC 
protein assay solutions and carried out according to manufacturer’s guidelines 
(BioRad, Hemel Hempstead, UK). Measurements were carried out on tissue 
homogenised using a glass homogeniser (Kontes, New Jersey, USA). The tissue 
was placed in a buffer, containing protease inhibitors (Complete Mini Protease 
Inhibitor Cocktail, without EDTA, Roche, Hertfordshire, UK) and homogenised 
on ice. The homogenate was then stored at -80oC until used in the protein assay. 
 
Briefly, 5 µl of homogenate was placed in a 96 well plate. 25 µl of solution A1 (20 
µl of solution S added to every 1 ml of solution A) together with 200 µl of Protein 
assay solution B (BioRad, Hemel Hempstead, UK) was added. This was carried 
out in triplicate, with an appropriate series of protein standards (1 - 2,000 µg.ml-1 
BSA) analyzed at the same time. Standard curves were produced and protein in 
tissue homogenates calculated from linear regression, see fig.2.7.  
 
The samples were mixed on a rotating plate and left for 15 mins. The plate was 
then placed in a spectrophotometer (Opsys MR, Dynex Technologies, Worthing, 
UK) and the plate read at 640 nm. 
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Fig 2.7: Protein standard curve. Sample standard curve from the BioRad protein 
assay, with absorption at 640 nm against concentration of BSA, µg.ml-1.  
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2.11 Tissue sample preparation for HPLC 
Tissue was collected from animals deeply anesthetised with isofluorane and 
immediately frozen and stored in liquid nitrogen. The tissue was stored in a 
cryovial until ready for freeze-drying. The lid of the cryovials were perforated and 
rapidly transferred to a freeze dryer pre-chilled at -90°C and left there for 48 hr. 
The lids of the cryovials were replaced and the tissue was then stored at -80°C.  
 
For the preparation of the homogenate, approximately 20mg of freeze-dried tissue 
was weighed and transferred into an ice-cooled ground-glass homogeniser 
(volume 1.5 ml). The weight was multiplied by 25, which gave the volume in 
millilitres of 0.4M perchloric acid that was added to the tissue. The tissue was 
then homogenised using a mechanical SS10 stirrer (Stuart Scientific, UK) at a 
speed of 500 RPM. Subsequently, the homogenate was transferred to an 
eppendorf tube and centrifuged at 4°C for 3 minutes.  
 
After transferring the supernatant into another cooled eppendorf tube, the pH of 
the extract was adjusted to 6.0 using 2M potassium hydroxide and pH strips 
(Sigma-Aldrich, Poole, Dorset, UK). The solution was once more centrifuged at 
4°C for 3 minutes, and the supernatant was then stored at -80°.  
 
2.12.1 High performance liquid chromatography 
The frozen homogenate of aorta was thawed for 30 minutes before injection of 20 
µl of sample into the chromatography system. Care was taken to remove all air 
bubbles from the HPLC system before running samples in triplicate. Samples 
were controlled by an SCL-10A (Shimadzu, Tokyo, Japan) controller unit, which 
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was interfaced with a PC. The sample injector (SIL-10AD, Shimadzu, Tokyo, 
Japan) also regulated the temperature of the samples, maintained at 19oC. These 
samples were then passed through a UV-detector (SPD-M10A, Shimadzu, Tokyo, 
Japan) and collector (FRC-10A, Shimadzu, Tokyo, Japan) (See fig. 2.8). 
 
2.12.2 HPLC Buffers 
The whole system was continuously flushed with phosphate buffers (A and B), at 
a rate of 1 ml.min-1, to optimise preservation of the adenine nucleotides. Buffer A 
consisted of 150 mM potassium dihydrogen orthophosphate solution and 150 mM 
potassium chloride solution, adjusted to pH 6.0 with potassium hydroxide. Buffer 
B was a 15% (v/v) solution of acetonitrile in buffer A. The amount of buffer B 
was changed linearly between the following time points: 0 minutes 0%, 3.5 
minutes 9%, 5 minutes 100%, 7 minutes 100%, 7.1 minutes 0%. The re-
equilibration time was 4.9 minutes resulting in a cycle time of 12 minutes 
between injections. 
 
Chromatographic separation was performed using a C18 reversed-phase column 
(5 RPC 4.6/150 analytical column, Amersham, Buckinghamshire, UK). Sample 
peaks were analysed using a chromatography data system, with the adenine 
nucleotide peaks monitored at 254 nm. The retention time and height of the peaks 
were analysed, with the adenine nucleotide concentrations derived from standard 
curves. Selections of samples were spiked with a suitable concentration of 
standard to demonstrate that the peaks identified the correct nucleotides. 
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2.12.3 Adenine nucleotide standard solutions 
Stock standard solution were prepared in 0.4M perchloric acid and adjusted to a 
pH of 6.0 using 2M potassium hydroxide and stored at -20°C. Fresh solutions 
were made before each assay, adding 0.4M perchloric acid adjusted to a pH of 6.0 
using 2M potassium hydroxide. Standard solutions covered the range from 0.5 to 
20 nM for ATP, ADP and AMP.  
 
 
 
 
 
 
 
 
 
 
 
Fig 2.8: The actual HPLC apparatus and setup used in the laboratory 
 
2.13 Drugs and solutions 
All drugs were prepared and diluted in water, unless stated otherwise. 
Cytochalasin D, glibenclamide, jasplakinolide, levcromakalim and PNU 37883A 
were all diluted in dimethyl sulphoxide (DMSO). The final concentration of 
DMSO in experimental solutions did not exceed 0.2% (v/v). This was shown not 
Loading Tray 
Buffers A & B HPLC  Column 
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to affect experimental results. Deta NO (Sigma-Aldrich, Poole, Dorset, UK) was 
dissolved in PBS. 
 
All chemicals were purchased from Sigma-Aldrich (Poole, Dorset, UK) unless 
otherwise stated. All antibodies were purchased from Molecular Probes 
(Amsterdam, Netherlands) and usually diluted in blocking buffer except Alexa 
Fluor 568 Phalloidin, Anti-α actin antibody, DNAse 1 antibody, were all 
dissolved in PBS. 
 
Physiological salt solution (PSS) containing in mM: NaCl 112, KCl 5, MgCl2 1, 
NaHCO3 25, NaH2PO4 0.5, KH2PO4 0.5, glucose 10, CaCl2 1.8. 
 
2.14 Statistical analysis 
All data are represented as mean ± SEM of n observations. Organ bath data was 
analysed and plotted with a non-linear curve fit and calculation of the EC50 using 
Graphpad Prism 4 (California, USA). These concentration-response curves were 
adjusting for matching and analysed for variance using two way ANOVA. 
Confocal microscopy data, generated by LaserPix, was analysed using Student’s 
T test. Significance was set at P < 0.05.  
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Chapter Three 
 
Does cytoskeletal disruption occur  
in an in vitro model of sepsis? 
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As mentioned in the introduction, the role of KATP channels in sepsis is well 
established (Landry & Oliver, 1992; Sorretino et al., 1999). However, the 
mechanism of their activation in sepsis is not well understood. The cytoskeleton is 
involved in the regulation of ion channels in various tissues (Strege et al., 2003; 
Schwiebert et al., 1994; Terzic & Kurachi, 1996), including vascular smooth 
muscle cells (Loffler-Walz and Quast 1998). Nitric oxide, the production of which 
is increased in sepsis, causes disruption of cytoskeletal proteins (Chakravortty & 
Kumar, 2000; Sandau et al., 2001). I therefore sought to investigate if cytoskeletal 
disruption was one of the mechanisms of KATP channel dysfunction in sepsis. 
  
3.1 Investigation of the cytoskeleton in an in vitro model of sepsis 
The role of the cytoskeleton in controlling KATP channel function was assessed by 
examining the actin cytoskeleton of rat abdominal aorta and mesenteric artery. I 
sought proof that the actin cytoskeleton is disrupted in vascular smooth muscle 
cells in sepsis. This was done using an in vitro model of sepsis, in tissues where 
vascular hyporeactivity was confirmed using the organ bath technique (as 
described in Chapter 2). Cytoskeletal organisation was examined in two ways; 
first with immunohistochemistry examining F and G actin in frozen sections and 
imaged via confocal microscopy, and second, by Western blot analysis of F and G 
actin levels. 
 
3.1.1 Vascular Hyporeactivity in an in vitro model of sepsis 
Figure 3.1 displays contractile responses to phenylephrine (PE) obtained in fresh 
mesenteric artery and fresh aorta over a concentration range (10-9 -10-5), as per 
O’Brien & Wilson (2001). Mesenteric artery responsiveness to the same agonist 
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in the in vitro model of sepsis is shown in fig. 3.2. In fig. 3.2A, the concentration-
response curve to PE for tissue incubated for 24 hrs is shown, with controls 
incubated in DMEM (n = 9) alone and septic tissue incubated in DMEM 
containing 0.1 µg.ml-1 LPS (n = 10). The control tissues responded to PE with a 
similar EC50 value (3.91 x10-9 M) to that of arteries (6.79 x10-9 M) not incubated 
in DMEM (described as “fresh”). However, the rings of tissue incubated in LPS 
were profoundly unresponsive to PE, barely giving any contractile response even 
to concentrations as high as 10-5M. This supported the validity of the in vitro 
model of sepsis in mesenteric artery at 24 hrs. 
 
By contrast control tissues incubated for 48 hr in DMEM demonstrated that PE 
was less efficacious and 10 times less potent, with a significantly lower maximal 
(Emax) contraction (0.4g vs 1.1g in fresh controls) and a higher EC50 value of 
1.20 x10-8M (fig 3.2B). This was either due to a greater degree of tissue damage 
to the mesenteric artery following 48 hr incubation or due to iNOS induction, 
which may be secondary to infection. Despite this, the contraction to PE was 
greater in tissues incubated in LPS for 48 compared to 24 hr (0.3g of tension 
compared to < 0.1g tension at 10µM PE, respectively fig. 3.3), which is consistent 
with previous findings from this laboratory whereby little hyporeactivity to PE 
was observed in tissues incubated for 48 hr in DMEM with 1 µg.ml-1 LPS 
(O'Brien, 2001). 
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Fig 3.1. Concentration-response curves to phenylephrine obtained in fresh 
tissue. Phenylephrine (PE 10-9 – 10-5M) was applied in a cumulative fashion to 
the organ bath. Concentration-response curves are shown for mesenteric artery 
(A) and aorta (B), giving EC50 values of 6.79 x10-9 M (n=15) and 9.17 x10-9 M (n 
= 10) respectively. All data are expressed as mean tension ± SEM.  
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Fig 3.2. Phenylephrine concentration-response curves in mesenteric artery 
following 24 or 48 hr incubation in absence or presence of LPS (0.1 µg.ml-1). 
Phenylephrine (PE 10-9–10-5 M) was added in a cumulative fashion to mesenteric 
arteries incubated for 24 hr (A) and 48 hr (B) in DMEM ± 0.1 µg.ml-1 LPS. The 
curves in (A) are significantly different (P < 0.0001, *) but not in (B) (P > 0.05). 
Data are expressed as mean tension ± SEM. n = 10 (24 hr Control), n = 9 (24 hr 
LPS), n = 6 (48 hr Control), n = 4 (48 hr LPS). 
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The results of aortic vascular reactivity in the long term in vitro model of sepsis 
are shown in fig. 3.3. In fig. 3.3A, the concentration-response to PE for tissue 
incubated for 24 hr is shown, with controls incubated in DMEM for 24 hr (n = 8) 
and septic tissue incubated in DMEM with 0.1µg.ml-1 LPS (n = 8). The septic 
tissue was almost completely unresponsive to PE. This supported the 
pharmacological validity of the in vitro model of sepsis in rings of aorta at 24 hr. 
The data were obtained from eight rings of aorta, taken from different animals, 
with pairing of the control and LPS rings. Aorta incubated for 48 hr (fig. 3.3B) 
had an EC50 of 4.15 x10-8 M in controls, with a similar maximum contraction seen 
in 24 hr controls.  Again, the rings incubated in LPS were completely 
hyporeactive, with a maximal response < 0.1g. The data were obtained from four 
rings of aorta, representing four different animals, with pairing of the control and 
LPS rings. Fig 3.4 demonstrates Levcromokalim concentration-response curves in 
an in vitro model of sepsis in rat aorta in presence or absence of LPS. Aorta was 
incubated for 24 hr (A) and 48 hr (B) in DMEM ± 0.1 µg.ml-1 LPS after which 
levcromokalim (PE 10-9–10-5 M) was added in a cumulative fashion to aortic 
rings. At both incubation time points, relaxation responses to Lev in the presence 
of LPS were significantly increased compared to control (P < 0.001). This 
therefore demonstrated that the in vitro model of sepsis demonstrated abnormal 
KATP channel pharmacology, with increased KATP channel opening.  
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Fig 3.3: Phenylephrine concentration-response curves in an in vitro model of 
sepsis in rat aorta in presence or absence of LPS. Aorta was incubated for 24 
hr (A) and 48 hr (B) in DMEM ± 0.1 µg.ml-1 LPS after which phenylephrine (PE 
10-9–10-5 M) was added in a cumulative fashion to aortic rings. At both incubation 
time points, contractile responses to PE in the presence of LPS were significantly 
depressed compared to control (P < 0.001, *). Data are expressed as mean tension 
± SEM, n = 8. 
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Fig 3.4: Levcromokalim concentration-response curves in an in vitro model of 
sepsis in rat aorta in presence or absence of LPS. Aorta was incubated for 24 
hr (A) and 48 hr (B) in DMEM ± 0.1 µg.ml-1 LPS after which levcromokalim (PE 
10-9–10-5 M) was added in a cumulative fashion to aortic rings. At both incubation 
time points, relaxation responses to Lev in the presence of LPS were significantly 
increased compared to control (P < 0.001, *). Data are expressed as mean tension 
± SEM, n = 8. 
* 
* 
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3.1.2 Summary of functional assessment of in vitro model 
Therefore, the results thus far demonstrate that the in vitro model of sepsis used 
was a valid model, demonstrating vascular hyporeactivity comparable to 
published data (Wilson, 2002; O’Brien, 2001; O’Brien 2005). It was also 
important to demonstrate that each piece of tissue used in the subsequent confocal 
imaging studies was functional and either a valid control or a valid representation 
of vascular smooth muscle from the in vitro model of sepsis. 
 
3.2 Confocal microscopy 
The previous results section demonstrated that the in vitro model of sepsis was 
valid, with confirmed vascular hyporeactivity consistent with data reported in the 
literature (Wilson, 2002; O’Brien, 2001; O’Brien 2005). Whilst each ring of aorta, 
from an individual rat, was assessed in the organ bath, another section of aorta 
from the same rat was snap frozen, subsequently sectioned and then stained 
according to the protocols detailed in the method section of the thesis (see Chapter 
2). This ensured each image obtained by confocal microscopy was from the same 
aorta of known contractile function.  
 
3.2.1 Confocal Method Development 
A substantial portion of the confocal microscopy experiments represent method 
development, both the development of the image acquisition protocols, as well as 
the image analysis techniques. In preliminary experiments, tissue sections were 
cut to 20 µm thickness. However, the penetration and uniformity of the staining 
was variable so thinner (10 µm) tissue sections were used for all subsequent 
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experiments. This produced more uniform staining and thus all images displayed 
are 10 µm thick. The first set of images were taken from control vessels so as to 
optimise laser and confocal settings for these samples. Transverse rings of aorta 
were studied. Initial focussing of the slides was carried out on the elastic lamina to 
help determine the limits of the imaging boundaries and to limit fluorophore 
deterioration. As my hypothesis was that sepsis disrupts the actin cytoskeleton, 
the experimental protocol had to be sensitive enough to observe a decrease in F 
actin staining, and potentially, an increase in G actin staining. Initial experiments 
were carried out on control tissues where the fluorophores were excited such that 
the emitted signal did not saturate pixel intensity, and that the pixel saturation 
approximated to a normal distribution. This was achieved by examining images 
with Lasersharp 2000 software (Biorad, Hemel Hempstead, UK) and plotting a 
histogram of the pixel intensity. Once images were obtained that were normally 
distributed, the same laser and confocal microscope settings were strictly adhered 
to for all subsequent images. This enabled the direct comparison of F actin 
quantification between images and experiments carried out on different days. 
 
In fig. 3.5 evolution of the method for confocal analysis is summarised. Once the 
control images were optimised, single images from each experimental tissue were 
obtained. The effect of LPS treatment on F and G actin staining was examined 
following a 24 hr and 48 hr incubation (n = 4 each, respectively). Based on the 
unacceptable size of the error bars in the initial experiments (data not shown) it 
was decided to take two images per section of tissue, henceforth known as the 
“two image” method. These were then analysed by the methods described in fig. 
3.6. The results for this analysis are displayed in fig. 3.11. On further reflection, I 
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decided that two images per tissue section did not appear representative of the 
whole vessel. Therefore, all of the sections were re-imaged, this time taking 
images from three different regions per slide, with the use of the Kalman function 
(mean of three image acquisitions) and a Z stack across 5µm (in 1µm) steps. 
Henceforth, this acquisition method will be termed the KZ method. For this, 
previous tissue samples were re-sectioned and stained, and the results of the KZ 
method shown in fig. 3.14. This showed that quantitatively different results were 
obtained between the two analysis methods (compare fig. 3.11 vs fig. 3.14), with 
the former showing a decrease in F actin at the 24 hr time point, while the latter 
showing no change.  Given this difference, a further three animals were used to 
obtain aorta incubated for 24 and 48 hr ± LPS (0.1 µg.ml-1). These were again 
imaged by the KZ method and analysed via the AOI method and the results 
shown in fig. 3.15.  
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Fig. 3.5: Schema for the evolution and development of the image acquisition 
protocols. All images were 1024 x 1024 pixels in size. Kalman is a function 
within Lasersharp 2000, which refers to the acquisition of the mean of a number 
of images to improve the signal to noise ratio of each image. The ultimate method 
is termed the KZ method for ease of understanding and reference. 
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3.2.2 Confocal Image Analysis 
The problem of how to analyse the images was approached as follows. The 
images were obtained via a sequential method of acquisition on the confocal 
microscope. This meant that an image analysis program (LaserPix, Biorad, Hemel 
Hempstead, UK) which recognised Biorad software coding, could take a colour 
image and separate the spectra into red, blue and green. These new images were 
then displayed as grey scale (0-255). The intensity of each pixel within a given 
area of interest (AOI) was then calculated using Laserpix (Biorad, Hemel 
Hempstead, UK). AOI intensity was initially calculated within multiple small 
squares within the image, with an average pixel saturation being taken.  
 
As described in detail later in this chapter, the earlier analysis method of 
analysing two images per section is termed the two image method for ease of 
reference and understanding (fig. 3.6). The final technique of selecting an AOI 
within each image of the KZ acquisition method (n = 15 per slide) is termed the 
AOI method, again for reference and ease of understanding (fig. 3.6). 
Does cytoskeletal disruption alter KATP channels in sepsis  
 98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.6: Schema for the evolution and development of the image analysis 
protocols. AOI stands for area of interest within an image. The ultimate analysis 
technique is termed the AOI method. 
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3.2.3 Elastin autofluorescence 
As described in chapter 2 an initial problem encountered was how to focus on the 
10 µm tissue sections, and from which area of the tissue to obtain images in a 
non-biased fashion. This was solved by focusing on the elastin contained within 
vessels, which autofluoresces in the green spectrum (488 nm). Thus, elastin 
autofluorescence was stimulated using the argon 488nm laser (see fig. 3.7). 
Moreover, elastin autofluorescence did not appear to vary between either 
mesenteric artery or aorta (fig. 3.7 A & B) or between long incubation periods, 
with and without LPS (fig. 3.7 C & D). Furthermore, the green He/Ne laser used 
to stimulate the Alexa 568 phalloidin did not cause elastin autofluorescence at 
power ranges below 50% (Fig. 3.8). Therefore, by using a 20% power setting, 
(fig. 3.8A), I am confident that the F actin signal was not contaminated by elastin 
autofluorescence. However, images of F actin obtained using 50% green He / Ne 
power (fig. 3.8C), or greater (fig. 3.8D), would have some elastin signal 
“contaminating” the F actin signal.  
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Fig. 3.7: Elastin autofluorescence stimulated by an Argon 488 laser. (A) fresh 
mesenteric artery, (B) fresh aorta, (C) aorta incubated in DMEM for 48 hr and (D) 
aorta incubated in DMEM containing LPS (0.1 µg.ml-1) for 48 hr. Bio-Rad 
Radiance 2100 confocal microscope at x60 magnification. 
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Fig. 3.8: Assessment of the autofluorescence of elastin in rings of mesenteric 
artery. Sections (10µm) were stimulated with a green Helium/Neon laser (543 
nm) at (A) 20% power, (B) 30% power, (C) 50% power and (D) 100% power, 
demonstrating no signal when < 50% power was used, eliminating false-positive 
actin staining. A Long pass filter (560 nm), short pass filter (570/590) were used. 
Bio-Rad Radiance 2100 confocal microscope at x60 magnification. 
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3.2.4 F & G Actin Staining 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.9 Specimen images of fresh mesenteric artery (10 µm sections) stained 
for F actin (on the left) and G actin (on the right). F actin was visualised using 
Alexa Fluor-568 Phalloidin (shown in red), while G actin was visualised using 
DNAse I Texas Red (again shown in red). In both cases, probes were stimulated 
with a green Helium/Neon laser (543 nm) and long pass filtered at 560 nm and 
short pass filtered at 570/590. Bio-Rad Radiance 2100 confocal microscope at x60 
magnification. 
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Fig. 3.10. Specimen confocal images of rat aorta from the long term in vitro 
model of sepsis. Example images of the experiments looking at F (A) and G (B) 
actin levels in aorta at 0 hr, 24 hr and 48 hr after incubation in DMEM ± LPS (0.1 
µg.ml-1). F actin was visualised using Alexa Fluor-568 Phalloidin, while G actin 
was visualised using DNAse I Texas Red. Stimulated with a green Helium/Neon 
laser (543 nm). A Long pass filter (560 nm) and a short pass filter (570/590) were 
used. Bio-Rad Radiance 2100 confocal microscope at x60 magnification. In each 
image actin appears red, whilst elastin appears green. 
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The results for the analysis of aorta incubated in LPS at varying time points 
(images fig.3.10) are displayed as means in fig. 3.11 (F actin) and fig. 3.12 (G 
actin). The level of F actin staining seen at 24 hr in the control tissue was not 
significantly different from tissue freshly removed from the animals (n = 4). 
However, there was a 52% reduction in F actin immunofluoresence (relative to 
background) in aorta at 24 hr incubation with LPS (53.7 ± 9.5 for control vs 25.5 
± 3 for LPS, n = 4; P < 0.05) (Fig. 3.11). In contrast, the level of G actin staining 
was not significantly different after 24 hr incubation with LPS in aortic rings (n = 
2) (Fig.3.12). At 48 hr, there is a trend towards a reduction in F actin in aorta. 
However, this was not statistically different (63.5 ± 28.4 for control vs 36.7 ± 6.2 
for LPS, P > 0.05) (Fig. 3.11). There is no significant difference in G actin levels 
in aorta at 48 hr (Fig. 3.12). With respect to mesenteric artery, there was also a 
65% reduction in F actin immunofluoresence (mean ± SEM) following a 24 hr 
incubation with LPS (71.5 ± 17.7 for controls vs 24.6 ± 2.5 for LPS, n = 4, P < 
0.05) (Fig.3.11). At 48 hr, F actin levels in mesenteric artery are difficult to 
interpret, as there was only one ring of control tissue (Fig. 3.11). There was no 
change in levels of G actin at the 24 hr time point (Fig. 3.12). At the 48 hr time 
point, there was a reduction in G actin levels in mesenteric artery control tissue 
when compared to LPS. However, this was not statistically significant (38.5 ± 2.1 
for control vs 55.9 ± 8.1 for LPS, P > 0.05) (Fig. 3.12). 
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Fig. 3.11: Quantification of F actin in aorta (A) and mesenteric artery (B) (see 
figure 3.10). Images were taken via the two image method. Data are shown as 
mean ± SEM. N values different for each condition, as indicated. (* = P < 0.05). 
n = 4 
n = 4 
n = 3 
n = 3 
n = 3* 
 
P< 0.05 
P < 0.05 
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Fig. 3.12. Quantification of G actin in sections from aorta (A) and mesenteric 
artery (B). (figure 3.6B). Tissue was incubated in DMEM ± LPS (0.1 µg.ml-1). 
Images were taken via the two image method. Data are shown as mean ± SEM. 
Where n = 2, no error bars are displayed. Data not statistically different.
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Further analysis was carried out because a fall in F actin was expected, which 
would be mirrored by a rise in G actin, which did not happen. Additionally, on 
review of the previous image acquisition methods (two image method), it was 
decided that two images per section was insufficient and unlikely to be a 
representative sample to quantify the α actin in each tissue section. Therefore, 
further experiments on the previous slides were performed using the KZ and AOI 
methods. These experiments quantifying F actin in aorta after 24 and 48 hr 
incubation in LPS are shown in Fig. 3.13. At 24 hr incubation with LPS (0.1 
µg.ml-1) there was no change observed, but 48 hr LPS saw a 40% reduction, 
consistent with the trend seen in Fig. 3.11. To reiterate, the images analysed in fig. 
3.13 were obtained with the revised acquisition method, namely using the Kalman 
function (mean signal from three acquisitions), with three images per slide and a 
Z stack taken across five microns for each image (KZ method). Furthermore, they 
were analysed with the revised analysis method of a ratio of the signal within an 
area of interest (AOI) over the tissue, to the reference AOI taken from the 
background (termed the AOI method). 
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Fig. 3.13. F actin immunofluoresence in aortic sections after incubation in 
LPS (0.1 µg.ml-1). Images, consisting of a Kalman function (x3), were taken from 
three areas per slide, with a Z stack (1µm steps) taken over 5µm for each area, 
(i.e. five images per Z stack, three Z stacks per slide / section of tissue). 
Therefore, each experiment represents x15 images. N = 3 (x45 images) 24 hr 
control, 24 hr LPS and 48 hr control. N = 2 (30 images) for 48 hr LPS (no error 
bars displayed because n = 2). If the Kalman x3 is accounted for, these data 
represent signals from 135 (for n = 3) and 90 (for n = 2) images, respectively. 
There was no difference between the 24 hr control and 24 hr LPS tissues. The 48 
hr LPS sample trended towards reduction, but was not significantly reduced 
compared to the 48 hr control. Data are displayed as mean ± SEM. 
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To examine the possibility that the revised method (KZ acquisition with AOI 
analysis) was the source of the difference in results, the samples from figure 3.11 
were re-sectioned and stained again. This time, images were obtained with the 
revised, KZ method, and analysed via the revised (AOI) method. The results of 
this repeated analysis are shown in fig. 3.14. This demonstrated no reduction in 
the levels of F actin at 24 hr of sepsis (unlike in fig. 3.11), but a fall in levels at 48 
hrs both in control and LPS-treated tissues. This result implies that the method of 
image acquisition could indeed affect the results.  
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Fig. 3.14 Mean F actin immunofluorescence of rings of aorta exposed to LPS 
for 24 hr and 48 hr incubation periods. These data were obtained from re-
sectioning and staining the same tissue used to generate data in fig. 3.11, but 
imaged (KZ) and analysed by the same method (AOI) as fig. 3.13. Thus a Z stack 
of five images, across 5 µm of tissue, and repeated in three areas per tissue section 
were analysed. N = 3 (x45 images) for fresh controls and 24hr LPS, n = 4 (x60 
images) for 24hr controls and n = 2 (x30 images) for controls and LPS treated 
tissue at 48 hr. Kalman images (n = 3) were taken for all images. Data are 
displayed as mean ± SEM. 
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To exclude deterioration of slides and fluorophores stored over a period of time 
and contributing to the source of the variation, it was decided to repeat the 
previous experiments with new samples. These samples were processed alongside 
fresh controls and all samples underwent concurrent organ bath experiments as 
previously described. These samples were only acquired by the KZ method and 
analysed via the AOI method. The results of these experiments are displayed in 
fig 3.15. These demonstrated a trend towards an increase in F actin levels in tissue 
that had been incubated in DMEM for 24 hr compared to fresh controls, though 
there was no difference in level of staining in DMEM compared with a 24 hr 
incubation in LPS (0.1µM). At a 48 hr incubation with LPS, there was a trend 
towards a decrease in F actin levels 
 
The results of the repeat staining and analysis of the samples contained in fig 3.14 
were combined with the results of the staining and analysis of the subsequent 
samples contained in fig. 3.15. This was valid because the same image acquisition 
method (KZ) and image analysis method (AOI) was utilised. Additionally, a new 
batch of Alexa 568 fluorophore was used for both. No statistically significant 
difference was observed between any of the samples (fig. 3.16). 
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Fig. 3.15 Mean F actin immunofluorescence in rat aorta sections repeated 
one year subsequent to original analysis , obtained via KZ technique and 
analysed via AOI technique. Data are displayed as mean ± SEM. 
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Fig. 3.16 Mean F actin immunofluorescence in rat aorta from 2003 and 2004, 
obtained via KZ technique and analysed via AOI technique. Data are 
displayed as mean ± SEM. 
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3.2.5 Confocal imaging and image analysis quality control  
Due to the considerable development in the way samples were imaged and 
analysed over a period of time,  a set of positive controls were designed to answer 
two fundamental questions: 
1) Are immunohistochemistry and confocal microscopy sensitive enough methods 
to demonstrate differences in F actin after incubation with the actin cytoskeleton 
disruptor cytochalasin D? 
2) Is there a significant reduction in F actin staining in rings of aorta after 
incubation with 10 µg.ml-1 LPS (100 times greater concentration than previously 
used) for 24 hr? 
 
Staining for F-actin under the conditions mentioned above are shown in fig. 3.17 
(1:40 Phalloidin staining), with quantification analysis shown in fig. 3.18. These 
demonstrated that the confocal technique was sensitive enough to observe a 
significant reduction in F actin after incubation with cytochalasin D (10 µM) 
(concentration developed from pilot data, not shown) for 2 hr. However, it also 
demonstrated that, after 24 hr of incubation in DMEM +/-LPS (10 µg.ml-1) there 
was a considerable reduction in F actin levels both in controls and in LPS (Fig. 
3.18). This result was at odds with results demonstrated in fig. 3.16 and is 
discussed later. These actual images suggested less staining of the tissues with 
phalloidin than previously seen, which raised the possibility that the decreased F 
actin in the 24 hr controls was an artefact. The immunohistochemistry protocol 
was adjusted to increase the permeabilisation step from 5 mins to 15 mins and to 
increase the concentration of Alexa 568 phalloidin from a 1:40 to a 1:20 dilution. 
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However, the images obtained produces over-saturated images in the control 
when stimulated with the previous laser settings. 
 A     B  
 
 
 
 
 
 
 C     D 
 
 
 
 
 
 
 
Fig. 3.17. Staining of F-actin with Phalloidin following cytochalasin and LPS 
treatment. Confocal images of aortic sections stained for F actin (in green) and a 
nuclear stain (TO-PRO in blue), with elastin appearing red. Aorta incubated (A) 
in DMEM for 2 hr, (B) in DMEM containing cytochalasin D (10 µM) for 2 hr, (C) 
in DMEM for 24 hr and (D) in DMEM containing LPS (10 µg.ml-1) for 24 hr. F 
actin: Alexa Fluor-568 Phalloidin was used at a dilution of 1:40 and the probe 
stimulated with a green Helium/Neon laser (543 nm). A long pass filter (560 nm) 
2 hr Control 2 hr Cyto D 10 µM 
24 hr LPS 10 µg.ml-1 24 hr Control 
20 µm 
20 µm 
20 µm 
20 µm 
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and a short pass filter (570/590) were used. Bio-Rad Radiance 2100 confocal 
microscope at x60 magnification. 
 
 
 
 
 
 
Fig. 3.18. Quantification of F actin staining in aorta. Mean data from examples 
shown in Fig. 3.17. Images analysed by  taking  AOI ratio to a background AOI as 
reference. n = 3 (Z stack of five images each, x3 per tissue, with a Kalman of 3 = 
135 images per group). There is an 80% reduction in F actin in the 2 hr Cyto D 
group when compared to 2 hr controls (P < 0.0001). Data are shown as mean ± 
SEM. 
 
 
* 
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A      B 
 
 
 
 
 
 
C      D 
 
 
 
 
 
 
 
Fig. 3.19. Images of F actin in positive controls using 1:20 phalloidin dilution. 
A. Aorta incubated in DMEM for 2 hr. B. Aorta incubated in DMEM + 
Cytochalasin D (10 µM) for 2 hr. C. Aorta incubated in DMEM for 24 hr. D. 
Aorta incubated in DMEM + 10 µg.ml-1 LPS for 24 hr, n = 1. F actin: Alexa 
Fluor-568 Phalloidin (Molecular Probes, Amsterdam, Europe). Stimulated with a 
green Helium/Neon laser (543 nm). A long pass filter (560 nm) and a short pass 
filter (570/590) were used. Bio-Rad Radiance 2100 confocal microscope at x60 
magnification. In these images actin appears green and elastin red. 
2 hr Control 2 hr Cyto D 10 µM 
24 hr LPS 10 µg.ml-1 24 hr Control 
20 
µm 
20 
µm 
20 
µm 
20 
µm 
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 3.2.6 Summary of confocal quantification experiments 
The results demonstrated that there was significant development and evolution of 
both the image acquisition and image analysis methods. The final KZ method for 
image acquisition is a representative sampling of each section. The AOI analysis 
method was a reproducible method for analysis of the images. The results 
demonstrated that the trend towards a reduction in levels of F actin seen in aorta 
sample with the earlier techniques was not reproducible. The trend towards 
reduction of F actin levels at 48 hr LPS persisted, but were not significantly 
different in the final analysis method used. 
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3.3 Assessment of α actin protein content by Western Blot 
Western blot analysis was carried out to examine the effects of LPS on the total α 
actin content in rings of aorta. On visual examination the Western blots (Fig.3.20) 
demonstrated no difference between the levels of total actin (F and G) seen at 24 
hr and 48 hr of LPS incubation when compared to either their time-matched 
controls, or to fresh controls. The fresh control samples in the 24 hr and 48 hr 
blots were from the same three animals. The 24 hr LPS samples (A) were taken 
from the same animals as the three samples labelled 24 hr controls, whereby half 
of the vessel was incubated in DMEM and the other half incubated in DMEM 
containing 0.1 µg.ml-1 LPS. The 48 hr experiments also represent tissue from 
three animals, with the same protocol as used in the 24 hr experiment. 
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A 
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Fig. 3.20. Western blots of total α  actin in rings of aorta at 0, 24 hr & 48 hr 
time points ± LPS. Western blots of total (F and G) alpha actin taken from rings 
of aorta in fresh tissues (fresh con) and those incubated in DMEM for 24 hr (A) 
and 48 hr (B). Lanes 1-3 represent homogenates from fresh controls (n = 3), 
where the same sample was used in both blots. Lanes 4-6 represent 24 hr (A) and 
48 hr (B) incubations in DMEM, while  lanes 7-9 represent samples incubated in 
DMEM with LPS (0.1 µg.ml-1) for 24 hr (A) and 48 hr (B), respectively (n = 3 for 
all conditions). 
 
24 hr 
Fresh Con 24 hr Con 24 hr LPS 
1 4 2 6 5 8 7 9 3 
42 kD 
48 hr 
Fresh Con 48hr Con 48hr LPS 
1 4 2 6 5 8 7 9 3 
42 kD 
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3.3.2 Separation of α  actin into filamentous (F) and globular (G) components 
The western blots in fig. 3.20 demonstrated that there was no change in the levels 
of total α actin in the in vitro model of sepsis at 24 hr and 48 hr time-points, 
despite the demonstration that these tissues were hyporeactive to PE in the organ 
bath studies (see fig. 3.2). Therefore, I proceeded to examine the hypothesis that 
the levels of F actin were reduced in sepsis, while that of G-actin may increase. 
As mentioned in Chapter 1, α actin consists of filamentous (F) and globular (G) 
actin. F actin is essentially polymerised G. Therefore, to examine levels of F actin, 
I initially had to separate out the G fraction from the F. This was achieved by 
developing a centrifugation protocol, which is summarised in the schema in fig. 
3.21, with the actual Western blots demonstrated in fig. 3.22 
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Fig. 3.21. F and G actin separation technique. Schema showing the modified 
centrifugation step to remove excess G actin from the F actin sample, a step 
introduced in the method described in fig.2.3. This step resulted in the generation 
of an F actin pellet free from contamination with G actin. 
F&G 
 
Homogenised 
Permeabilised 
+ Phalloidin 
226,000 g 
60 mins 
Pellet 
 
F 
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C       D 
 
 
 
 
 
 
 
Fig. 3.22. Western blots showing F actin separation. Positive controls for F and 
G actin are shown, where each blot is taken from two vessels, with half of the 
sample incubated for 4 hr in phalloidin (F actin control) and half incubated for 4 
hr in cytochalasin D (G actin control). Each sample was further divided into 
unspun (U) or those that have undergone an additional centrifugation step (S) at a 
speed, time and temperature as indicated on the blot. Incubation time was 4 hr for 
all samples. 
   200,000g / 1 hr @ 4oC 
S U U U U S S S 
Vessel 1 Vessel 2 
CyD CyD Phall Phall 
226,000g/ 1 hr @ 4oC 
S U U U U S S S 
CyD CyD Phall Phall 
Vessel 1 Vessel 2 
    307,000g / 1.5 hr @ 4oC 
S U U U U S S S 
Cyto D Cyto D Phall Phall 
Vessel 1 Vessel 2 
260,000g 1 hr @ 4oC 
S U U U U S S S 
Phall Phall 
Vessel 1 Vessel 2 
Cyto D Cyto D 
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The separation of F and G actin was essentially achieved by modifying the 
centrifugation step. The sample was initially spun at 307,000g for 1.5 hr at 4oC 
(fig.3.22A). This displayed contamination of the F actin sample with G actin since 
the tissue incubated in cytochalasin D still had signal after the centrifugation step 
(labelled “S”), when compared to the sample of tissue which has not undergone 
this step, (labelled “U”). The reduction of the centrifugal force to 260,000g for 1 
hr displayed a similar picture (fig.3.22B). Reduction to 200,000g for 1 hr caused 
significant loss of the F actin signal (fig.3.22C) suggesting that this force was not 
enough to sediment F actin. However, centrifugation of the F actin sample at 
226,000g for 1 hr at 4oC displayed clear separation of the F and G actin (fig. 
3.22D).  
 
3.3.3 Assessment of F actin in 24 hr & 48 hr in vitro models of sepsis 
This centrifugation protocol was then applied to aortic samples incubated for 24 
hr and 48 hr in LPS (0.1 µg.ml-1). The Western blots showed no difference in F 
actin levels in tissue incubated in LPS for either 24 (fig.3.23A) or 48 (fig.3.23B) 
hr when compared to their respective time controls or when compared to fresh 
controls. The fresh controls in A and B were from the same tissue samples, n = 3, 
while the 24 hr and 48 hr samples were from three separate animals, with pairing 
(same animal) of the appropriate controls with the LPS samples.  
 
The blots in fig. 3.23 were incubated in anti-alpha actin mouse antibody at a 
1:10,000 dilution. These blots appeared saturated and were therefore stripped of 
antibody (as per ECL  Western blot protocol) and then re-exposed to anti-alpha 
actin mouse antibody at a higher (1:50,000) dilution (fig. 3.24). These blots 
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appeared to suggest that there was less F actin in all of the 48 hr samples 
(compare A with B). However, on more careful inspection of lanes 7-9 in both 
blots, the very same fresh control tissue samples appeared to give different signal 
strengths. This was therefore more likely to be due to differential stripping of the 
blots. 
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Fig. 3.23. Western blots of aorta tissue, staining for F actin using 1: 10,000 
anti-alpha actin antibody. Shows Western blots of F actin from rings of aorta 
incubated for 24 hr (A) and 48 hr (B). Anti-alpha actin mouse antibody was used 
to identify F actin (1:10,000 dilution). Lanes 1-3 represent incubation in DMEM 
with LPS (0.1 µg.ml-1) for 24 hr (A) and 48 hr; both blots (A and B) were loaded 
with the same fresh control samples, as a between-blot control. Lanes 4-6 of both 
blots represent 24 hr (A) and 48 hr (B) incubations in DMEM, lanes 7-9 of both 
blots represent homogenates from fresh controls (n = 3 for all conditions). 
1 4
  
2 6 5 8
  
7 9 3 
Fresh Con 24hr Con 24hr LPS 
24hrs 42 kD 
1 4
  
2 6 5 8
  
7 9 3 
N = 3 
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48hrs 42 kD 
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Fig. 3.24. F actin using 1: 50,000 dilution of anti-alpha actin antibody. 
Western blots of F actin from rings of aorta incubated for 24 hours (A) and 48 
hours (B). These blots were the same as those in fig. 3.23, but were stripped of 
antibody and re-incubated with anti-alpha actin mouse antibody, but this time at a 
1:50,000 dilution. Lanes 1-3 represent incubation in DMEM with LPS (0.1 µg.ml-
1) for 24 hours (A) and 48 hours, respectively; both blots (A and B) were loaded 
with the same fresh control samples, as a between-blot control. Lanes 4-6 of both 
blots represent 24 hour (A) and 48 hour (B) incubations in DMEM, with Lanes 7-
9 of both blots represents homogenates from fresh controls (n = 3 for all 
conditions). 
N = 3 
1 4  2 6 5 8  7 9 3 
Fresh Con 24 hr Con 24 hr LPS 
24hrs 42 kD 
1 4    2 6 5 8   7 9 3 
Fresh Con 48 hr Con 48 hr LPS 
48hrs 42 kD 
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3.3.4 Summary of Western blot experiments 
The Western blot experiments demonstrated there was no change in the levels of 
total α actin (F and G) in rat aorta in an in vitro model of sepsis (fig. 3.20). The 
experiments also demonstrated the development of a reproducible technique for 
the separation of F and G actin in this tissue. This separation was best achieved 
using centrifugation of homogenates of rat aorta at 226,000 g for 1 hr at 4oC (fig. 
3.22). Furthermore, there was no reduction in the levels of F actin in rat aorta seen 
at 24 hr and 48 hr time points in an in vitro model of sepsis (fig. 3.23). However, 
the concentration of anti-α actin antibody used (1:10,000) may have been too high 
and that a lower concentration may be required (fig. 3.24). The Western blots also 
demonstrated that the stripping of previously stained blots was a variable 
technique (fig. 3.24). 
 
3.4 Discussion of results 
In patch-clamp studies, once the KATP channel is opened, application of ATP to 
the intracellular surface of the channel is insufficient to close the channel, unless 
further G actin is added (Terzic, 1996). This pattern of dysfunction, which 
includes increased agonist opening and decreased ability of the antagonists to 
close the channel, is remarkably similar to the pattern seen in in vitro models of 
sepsis (Wilson, 2002). With this in mind, I investigated the hypothesis that 
cytoskeletal disruption underlay the altered KATP channel pharmacology in sepsis. 
 
The results demonstrated that vascular tissue obtained from Sprague-Dawley rats 
was still functional post-dissection, and on incubation with DMEM and LPS 
behaved in a reproducible fashion (Fig.3.1-3.3) (Wilson, 2002).  
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I developed a method for the study and quantification of alpha actin, using 
immunohistochemistry and confocal microscopy (Fig.3.5 & 3.6). However, the 
reproducibility of the quantification method was variable and largely did not 
correlate with functional data. When considering the final method of image 
analysis, there was little change in F-actin levels at a time (24 hrs) where rings 
were found to be hyporeactive to PE in the presence of LPS (Fig.3.16). There 
were however differences in the quantification results that depended on the 
method of acquisition and analysis (compare fig. 3.11A vs fig. 3.14 vs fig. 3.16). 
However, as these methods evolved, the KZ method was probably a more 
representative sampling of the tissue, with more images per section. This 
demonstrated no significant decrease in F actin at 24 hr and an insignificant trend 
towards a decrease on F actin at 48 hr (Fig. 3.16).  
 
There were no significant differences seen in the levels of G actin in any of the 
tissues (fig.3.12). However, due to the problems with the early methods and the 
need for significant development of method, not enough time was available to 
analyse the G actin levels using the confocal microscope. Once the problems of 
reproducibility were recognised, the majority of time and effort went into 
optimising the technique the KZ method of acquisition and the AOI method of 
analysis (Fig. 3.6). I therefore concentrated on the F actin signals in aortic tissue. 
 
The biochemical assessment of the actin cytoskeleton also required significant 
and time-consuming method development. Western blots of total actin did not 
demonstrate any change in sepsis (Fig. 3.20). However, this could have been as a 
consequence of the filamentous F actin being converted into globular G actin. 
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Having developed a technique for separation of F and G actin (Fig. 3.21 and Fig. 
3.22), I demonstrated that there was no change in the levels of F actin at the 24 hr 
LPS or 48 hr LPS time points (Fig. 3.23). The Western blots demonstrated in fig. 
3.23 were overly saturated, so I therefore attempted to re-examine the blots with a 
weaker concentration of antibody (1:50,000 vs 1:10,000). However, the process of 
stripping the antibody from the gels in order to re-stain them caused artefactual 
differences in staining (Fig. 3.24). This is seen in the differences in the staining of 
the fresh control samples, which are from identical tissue preparations. The fresh 
controls are less stained on the 48 hr blot (Fig. 3.24B) when compared to the 24 hr 
blot (Fig. 3.24A).  
 
If time had permitted, I should have also gone on to run gels of the supernatant in 
the F and G actin separation protocol (Fig. 3.21). This would have allowed me to 
assess any changes in the levels of G actin. However, the primary hypothesis was 
that there was a change in F actin in sepsis. The blots should also have been 
stained for a house-keeping protein as an internal control. However, there was a 
limited supply of tissue homogenate to work with, because of the repeated 
running of gels in optimizing the method of extraction and method of staining. 
Each sample of tissue run on a Western Blot was from an overall piece of tissue 
that had also been examined in the organ bath for vascular hyporeactivity, as well 
as in the confocal microscope. Notwithstanding this, the method for separation of 
F and G actin was reproducible and valid. Again, because of the considerable time 
spent during method development and despite starting out to examine both aorta 
and mesenteric artery, I was only able to examine rat aorta. Ideally, all of these 
experiments should also be repeated in rat mesenteric artery. 
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My original hypothesis stated that sepsis would disrupt the cytoskeleton. 
However, I was unable to demonstrate any correlation between the confocal, 
biochemistry and organ bath results. One potential hurdle in quantifying changes 
in the cytoskeleton is that actin is such an abundant protein. Hence, a change in F 
actin of less than fifty percent of total may be difficult to observe against a high 
background signal. This was demonstrated by the fact that the homogenates 
loaded onto the SDS-page gels had first to be diluted by a factor of ten, with a 
dilution of the anti-alpha actin antibody as low as 1 in 50,000 for some 
experiments. 
 
If there was a contribution to vascular hyporeactivity, this may be related to 
alteration of the force-transduction mechanism of vascular smooth muscle, rather 
than alteration of the control mechanisms of the KATP channel. Alteration in the 
actin-myosin coupling required for muscle contraction may be impaired in sepsis, 
indirectly supported by the evidence that total actin leaks from cells into plasma 
during sepsis (Mounzer & Moncure, 1999; Dahl & Schiodt, 2003). However, I 
saw no changes in total actin (Fig. 3.20).  
 
Interestingly, there appear to be differences between the responses of aorta and 
mesenteric artery from the same animal, dissected at the same time and incubated 
in identical conditions. The mesenteric artery appeared to show more recovery 
from hyporeactivity in the 48 hr model of sepsis, whereas rings of aorta were 
equally hyporeactive at 24 and 48 hr. (fig. 3.4B and fig.3.5B respectively). 
Notwithstanding this, the analysis of the confocal images suggests that there may 
have been more F actin in mesenteric artery when compared to aorta (see fresh 
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controls in fig. 3.11A & 3.11B). There did not appear to be any differences in the 
quantified levels of G actin (see fresh controls fig.3.12A 7 3.12B). These 
characteristics may be similar to the differences in the ratio of F and G actin seen 
between striated and smooth muscle (9:1 versus 1:1) (Cipolla, Gokina & Osol, 
2002). This may reflect differences in the intravascular pressure that the vessels 
are exposed to.  
 
3.5 Conclusion 
The semi-quantitative techniques I utilised were probably inadequate tools with 
which to answer the question “does cytoskeletal disruption alter KATP channel 
function in sepsis?” Study of more subtle, sub-cellular, cytoskeletal proteins (such 
as syntaxin Ia) in cellular or electrophysiological studies (such as patch clamping 
or rubidium efflux) may offer a more targeted and fine-tuned approach, especially 
in trying to determine if the cytoskeleton alters ion channel function in those 
tissues. Alternatively, examination of actin in isolated VSMCs, via the confocal 
microscope, may have highlighted alterations in the cellular organisation of actin, 
as a stress response, rather than trying to quantify changes on actin (Saidi et al., 
1997). 
 
It is unlikely that the actin cytoskeleton of vascular smooth muscle cells is 
completely unaffected by sepsis, given that it is such an abundant protein and the 
evidence that NO alters actin in small intestine (Banan, Fields, 2000), kidney 
(Sandau, 2001) and liver (Aslan, 2003). Altered actin in sepsis is also evidenced 
by altered actin-binding proteins (e.g. gelsolin) in sepsis (Lee & Waxman, 2007). 
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Targeting the cytoskeleton is probably not a therapeutic option in view of the 
widespread role of the cytoskeleton. However, actin may itself be injurious in 
sepsis (Erukhimov et al, 2000), and mopping up plasma actin may prevent this 
injury in sepsis (Messaris, 2007).  
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Chapter Four 
 
Does Nitric Oxide directly  
enhance KATP channel function  
in sepsis? 
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Introduction 
Activation of the ATP-sensitive potassium (KATP) channel, via the iNOS pathway, 
contributes to the vascular hyporeactivity seen to catecholamines in sepsis (Hall et 
al., 1996; Sorrentino et al., 1999). Relaxation to KATP channel openers (e.g. 
levcromakalim) is potentiated in in vivo and in vitro models of sepsis (Sorrentino 
et al., 1999; Chen, 2000; Wilson, 2002). The precise mechanism of this 
potentiation is unknown, but in short-term (4hr) LPS models this probably 
involves NO since potentiation of levcromakalim-induced relaxation could be 
prevented by pre-treatment with an iNOS inhibitor (Wilson, 2002). However, in 
in vitro models greater than 6 hours, inhibition of NO production only partially 
reversed hyporeactivity to PE or potentiation of levcromakalim-induced 
relaxation (O’Brien et al., 2001; Wilson & Clapp, 2002). This may be because 
mechanisms other than the NO pathway are involved, e.g. the arachadonic acid 
pathway (O’Brien et al., 2001). Alternatively, it may have been because 
irreversible damage had occurred to the KATP channel (Wilson & Clapp, 2002). 
Indeed, the KATP channel function appears to be altered in in vitro models of 
sepsis, such that there is an uncoupling of the ability of drugs acting via the SUR 
to close the channel (Wilson & Clapp, 2002; O’Brien et al., 2005), but drugs 
acting directly on the ion-channel pore retain their ability to close the channel 
(Wilson & Clapp, 2002; O’Brien et al., 2005). Therefore experiments were 
designed to examine whether or not I could enhance KATP channel function by 
exposing tissues to exogenously generated NO, to explore the hypothesis that this 
was a direct NO effect and not secondary to any other down-stream consequences 
of LPS, e.g. cytokines or arachidonic acid.  
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4.1 iNOS induction and NO production in an in vitro model of sepsis 
N-(3-(Aminomethyl)benzyl)acetamidine (1400W) is a highly specific inhibitor of 
iNOS, which works by preventing the dimerisation of iNOS both in vivo and in 
vitro models (Garvey, et. al 1997). This inhibitor was thus used to assess whether 
it could reverse vascular hyporeactivity induced by LPS in rat aorta. For these 
experiments aortic rings were incubated in DMEM with 1400W (10 µM) (Garvey 
et al., 1997) in the presence and absence of LPS (0.1 µg ml-1) for either 24 hrs or 
48 hrs as indicated. 1400W is a slow, but tight binding and highly iNOS selective 
inhibitor (Garvey et al., 1997) and the inhibition of iNOS lasts for over 2 hrs after 
exposure (Garvey et al., 1997). Fig. 4.1 shows that 1400W was able to 
substantially reverse vascular hyporeactivity induced by 48 hr LPS causing a 
significant shift in the EC50 for PE (7.1.10-8 M vs 6.7.10-8 M, P = 0.001). 
Surprisingly, it had little effect at the 24 hr time point (P > 0.05).  
 
In control tissues no significance difference was seen with co-incubation of 
1400W, suggesting insignificant iNOS induction in control tissues following 
incubation in DMEM (fig. 4.1).  
 
Fig. 4.2 demonstrates that mesenteric artery incubated at the 48 hr time point 
contracted sub-maximally. Control tissue incubated with 1400W (10 µM) was 
similarly affected, excluding iNOS induction as a cause of the hyporeactivity in 
controls. Data are not displayed for 24 hr LPS and 1400W in mesenteric artery. 
This was because of a lack of an endothelial response in the majority of these 
tissues. 
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Fig 4.1 Effects of the iNOS inhibitor 1400W on aortic vascular reactivity in 
an in vitro model of sepsis. PE (10-9–10-5 M) concentration-response curves at 24 
hr (A) and 48 hr (B) time points, where tissues were incubated in DMEM ± 0.1 
µg.ml-1 LPS in the presence and absence of 1400W (10 µM). Data are displayed 
as mean ± SEM (n = 4 for all groups). 1400W causes a significant reversal of 
sepsis-induced hyporeactivity at the 48 hr (EC50 = 7.1.10-8 M vs 6.7.10-8 M, P = 
0.001, *), but not the 24 hr time point (P > 0.05).  
-10 -9 -8 -7 -6 -5 -4
0.0
0.5
1.0
1.5
2.0
Control + 1400W
LPS + 1400W
Control
Aorta 24 hr
LPS
Dose log [PE]Concentration, log [PE] M 
-10 -9 -8 -7 -6 -5 -4
0.0
0.5
1.0
1.5
2.0
Control + 1400W
Control
LPS
Aorta 48 hr
LPS + 1400W
Dose log [PE]Concentration, log [PE] M 
* 
* 
* 
Does NO directly alter KATP channel function in sepsis? 
 138 
 
A 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
Fig 4.2 Effects of the iNOS inhibitor 1400W on the in vitro model of sepsis in 
mesenteric artery. PE (10-9–10-5 M) concentration-response curves at 24 hr (A) 
and 48 hr (B) time points. Tissue was incubated in DMEM ± 0.1µg.ml-1 LPS ± 
1400W (10 µM). Data are displayed as mean ± SEM. 1400W did not cause a 
significant inhibition of the LPS-induced hyporeactivity at the 24 hr or 48 hr time 
points (P > 0.05). (24 hr control, n = 9; 24 hr control + 1400W, n = 3; 24 hr LPS, 
n = 10; 48 hr control, n = 6; 48 hr control + 1400W, n = 2; 48 hr LPS, n = 4; 48 hr 
LPS + 1400W,n=2).
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4.2 Determination of the Deta NO concentration required to mimic NO 
release in an in vitro model of sepsis 
To examine the hypothesis that opening of the KATP channel in sepsis was a direct 
NO effect on the channel, a pure NO donor (Deta NO) was selected (Griffiths, 
2001) (see chapter 2, section 2.4.5, p 7). Previous results from this laboratory 
have shown in a similar organ culture model to the one used here that LPS 
produces micromolar (2 µM mg-1 protein) levels of nitrite (breakdown product of 
NO) in the supernatant of tissues incubated for 20 hrs (O’Brien, 2005). Therefore, 
I calculated what concentration of Deta NO was required to release a similar 
range of NO. To ensure sufficient concentrations of NO to detect an effect, a 
concentration of 10 µM NO was selected. It is known that one mole of Deta NO 
releases 2 moles of NO and that the decay half life (t1/2) for Deta NO is 1200 mins 
at 37oC at pH 7.4 (Sigma Aldrich data sheet). Using the graphical analysis 
programme GraphPad Prism, a theoretical decay curve was plotted and it was 
possible to calculate what concentration of Deta NO would be required to release 
10 µM NO over a given time period (fig. 4.3). Thus 10 µM of Deta NO would 
theoretically decay by half after 20 hr, at 37oC, pH 7.4, thereby releasing 10 µM 
of NO. Confirmation of the amount of NO released by the in vitro model of sepsis 
(LPS 1µg/ml) and by 10 µM Deta NO was sought by measuring the amount of 
nitrite produced by both experiments. Nitrite levels were measured using the 
Griess assay, which is based on a diazotisation reaction, with a subsequent 
colorimetric measurement (Chapter 2). The data in fig 4.4 demonstrates that the in 
vitro model produced 3.1 µM nitrite per µg protein compared to 2.0 µM nitrite per 
µg protein in controls (n = 7, P < 0.05). Additionally, I demonstrated that 10 µM 
Deta NO produced 11.1 µM nitrite per µg protein (fig 4.4). This was greater than 
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the level of nitrite produced by the in vitro model of sepsis and greater than the 
control tissue (n = 5, P < 0.005) (fig. 4.4). This confirmed that the incubation of 
rings of aorta in 10 µM Deta NO for 20 hr, at 37oC and pH 7.4 released an 
adequate amount of NO. This then enabled me to investigate whether or not NO 
had a direct effect on the KATP channel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.3. Deta NO theoretical decay curves based on a half-life of 20hr at 37oC, 
pH 7.4. This theoretical decay curve demonstrates that to achieve the release of 
10 µM NO (to mimic NO release in the in vitro model of sepsis) requires 
incubation of tissues with 10 µM Deta NO for 20 hr.  
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Fig. 4.4. Nitrite levels produced by Deta NO or LPS after 20hr incubation. 
Rings of aorta are incubated in DMEM in the absence or presence of either LPS 
(1 µg/ml) or 10 µM Deta NO for 20 hr, 3.15 µM nitrite per µg of protein were 
generated. This was statistically significantly higher than the nitrite generated in 
aorta incubated in DMEM alone (1.98 µM per µg protein) (* = P < 0.05). 
Incubation of tissue in 10 µM of Deta NO for 20 hr generated sufficient nitrite 
(11.12 µM per µg protein) to mimic this in vitro model of sepsis. This was also 
significantly greater than controls (** = P < 0.005). Data are displayed as mean ± 
SEM, where the n value for each condition is as indicated. 
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4.3 KATP channel function in an in vitro model of sepsis 
The contribution of KATP channels to the vascular hyporeactivity seen in sepsis 
can be studied by examining the effect of KATP channel openers on pre-contracted 
rings of blood vessel (Chen, 2000). In sepsis, the relaxation curve to the KATP 
channel opener pinacidil was reported to be shifted to the left in septic animals 
(Chen, 2000), possibly indicating that a sepsis-induced intracellular factor may be 
synergising with pinacidil to open more KATP channels and cause greater 
relaxation (Chen, 2000). In an in vivo model of sepsis (described in Chapter 2, 
section 2.3), I found a potentiation of levcromakalim-induced relaxation in 
thoracic aorta taken from these septic rats at 24 hr after the insult (fig. 4.5). There 
was a small but significant left-shift in the concentration response curve (EC50 
1.9.10-7 M compared to EC50 3.4.10-7 M in sham animals; n = 4; n=8, P = 0.0004) 
 
Subsequently, a series of experiments were performed whereby rat aorta was pre-
incubated in Deta NO (10 µM) for 20 hr, and the relaxant response to different 
concentrations of levcromakalim assessed. If the potentiation of KATP channels in 
sepsis were due to a direct NO effect, then I would predict a left-shift of the 
levcromakalim concentration response curves in the tissue incubated in 10 µM 
Deta NO. In these studies, rat aortae were pre-contracted with phenylephrine (3 
µM) and levcromakalim-induced (10-9 – 10-5M) relaxation examined in the 
presence of Deta NO (10 µM) at 4 hr and 20 hr time points. Pre-incubation with 
Deta NO did not affect relaxation to levcromakalim at the two time points (Fig. 
4.6 & Fig. 4.7).  
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Fig. 4.5 Levcromakalim (10-9 – 10-5M) relaxation curves in rat thoracic aorta 
taken from an in vivo model of sepsis. Tissue was pre-contracted with PE 
(3µM). 24 hr sham animals: EC50 = 3.4.10-7M, n=4. 24 hr septic animals: EC50 = 
1.9.10-7M, n = 8. (P < 0.005, *). Mean % relaxation ± SEM. 
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Fig 4.6 A. Levcromakalim relaxation response curve generated in the presence 
or absence of Deta NO 10 µM, where rings have been incubated for 4hr (A) or 20 
hr (B). Tissues were pre-contracted with PE (3µM) and data shown as mean % 
relaxation ± SEM.  
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Fig 4.7: EC50 values obtained from concentration-response curves for 
levcromakalim in rat thoracic aorta. Two-way ANOVA (repeated measures) 
were used to analyse differences between the concentration-response curves. 
 
4.4 Discussion of NO activation of the KATP channel 
Increased iNOS expression is a central feature of sepsis. There are increased 
levels of nitrate and nitrite and increased activity of iNOS in both ex vivo and in 
vitro (Hernanz et al., 2004) and in vivo (Rees et al., 1998) models of sepsis. 
Increased levels of NO breakdown products have been reported in septic patients 
(Evans et al., 1993; Ochoa et al., 1991), with evidence of nitration in skeletal 
muscle. Nitric oxide plays a significant role in activation of the KATP channel in 
sepsis (Hall et al., 1996; Sorrentino et al., 1999; Thiemermann, 1997). The exact 
mechanism of activation remains unknown, but is likely to involve the NO-cGMP 
pathway (Wilson, 2002; O’Brien et al., 2001; Han et al., 2002). 
 
One of the earliest indications that NO may be activating KATP channels in sepsis 
came from the work of Miyoshi and colleagues (Miyoshi, Nakaya et al. 1994). 
They demonstrated in patch-clamp studies from cultured coronary cells, that L-
Arginine, which preferentially activates iNOS, caused persistent activation of 
KATP channels in endotoxin-treated but not control cells. Activation was blocked 
 4hr Control 4hr DetaNO 
(10 !M) 
20hr Control 20hr DetaNO 
(10 !M) 
 
EC50 
 
7.0 x10-8 M 
 
5.7 x10-8 M 
 
2.1 x10-7 M 
 
1.6 x10-7 M 
N 4 4 4 4 
P value  0.1  0.57 
 
Does NO directly alter KATP channel function in sepsis? 
 146 
by methylene blue, an antioxidant with both guanylate cyclase and NO synthase 
inhibitor activity, suggesting involvement of both NO and cyclic GMP. 
Interestingly, the effects could not be mimicked by NO donors even though they 
produced greater amounts of NO in the bathing medium. Likewise, the 
involvement of KATP channels in NO donor-induced relaxation may require prior 
endotoxin treatment (Wilson and Clapp 2002) or the presence of superoxide 
(Ohashi, Faraci et al. 2005). This raises the intriguing possibility that the iNOS 
pathway yields additional or more stable factors that work in concert with NO to 
cause persistent channel activation in sepsis. Indeed calcineurin activity is 
substantially reduced by nitric oxide and/or superoxide (Sommer, Coleman et al. 
2002), the net effect would be to hyperphosphorylate the KATP channel and cause 
substantial opening even at normal ATP levels (Wilson, Jabr et al. 2000). 
Moreover, peroxynitrite, a much more reactive species than NO, is a powerful 
oxidant capable of nitrating tyrosine residues, causing lipid peroxidation and 
reacting with thiols and iron-containing compounds. Superoxide produces 
glibenclamide-sensitive relaxation in carotid and cerebral vessels, involving both 
cyclic GMP-dependent and cGMP-independent mechanisms (Wei, Kontos et al. 
1998; Ohashi, Faraci et al. 2005) and is a widespread dilator of many vascular 
beds.  
 
I investigated whether or not there was a direct effect of NO on the KATP channel, 
initially by trying to replicate the increased relaxation to the KCO levcromakalim. 
Deta NO is a pure NO donor, producing two moles of NO for every mole of Deta 
NO that decays. However, despite generating levels of NO similar to that released 
in a LPS in vitro model of sepsis (10 µM), I was unable to mimic potentiation of 
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the KATP channel seen in sepsis (Chen et al., 2000; Wilson & Clapp, 2002). The 
data demonstrated that nitric oxide was involved in the vascular hyporeactivity 
seen in the in vitro model of sepsis (fig. 4.1). Therefore, the NO pathway is 
involved in activation of the KATP channel, but this is not a direct effect of NO on 
the proteins of the channel, and is likely to involve down-stream effectors, 
possibly cGMP and PKG (Han et al., 2002). It is possible that despite the 
calculations utilising the decay characteristics of Deta NO, sufficient levels of NO 
did not penetrate the cell to alter KATP channel function. However, the 
measurement of nitrite levels in the DMEM used demonstrated levels in the 
correct range (O’Brien et al., 2001) and 1400W is very tissue permeable (Garvey 
et al., 1997). Notwithstanding this, in sepsis NO may be produced in a variable 
pattern maybe with peaks in production, whereas, the NO released via Deta NO is 
based on decay kinetics, in a more gradual fashion (fig. 4.3). The use of tissue 
instead of cells may have inadvertently mopped up and absorbed excess NO, 
possibly via the production of nitrated and nitrosylated thiols (Dalle-Donne, 
2000). The in vitro model of sepsis did not include FBS (O’Brien et l., 2001), one 
of the best-known buffers of NO, but a slow-release form of nitrosothiols (Dalle-
Donne, 2000). 
 
The lack of significant reversal at 24 hr may be secondary to the washing out of 
1400W in the organ bath during the priming of the tissue, without the 
reapplication of 1400W just prior to the cumulative concentration-response curve. 
However, 1400W was present for the entire duration of the incubation prior to 
placing the rings in the organ bath. Therefore, in LPS-treated tissue, iNOS 
induction may occur, but its dimerisation is prevented by the 1400W (Garvey et 
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al, 1997). 1400W is a tightly binding inhibitor of iNOS (Garvey et al., 1997). It is 
5000-fold more selective for iNOS than eNOS and is highly selective for rat tissue 
(Garvey et al., 1997). Additionally, its effects last for at least 2 hours (Garvey et 
al., 1997) and may even last longer than this. However, in view of the partial 
response seen in aorta at 48 hr (fig. 4.1 B), there may have been a washout effect. 
Interestingly, other authors have only added 1400W to the organ bath, prior to 
application of vasoconstrictors (O’Brien et al., 2001; Wilson, 2002). Whilst this 
may not be an issue for short (4 hr) incubation periods (Wilson, 2002), it is likely 
to be important in models of sepsis that are significantly longer, as demonstrated 
by O’Brien and colleagues (O’Brien et al., 2001). NO production occurs around 2 
hours after incubation with LPS (Hall et al., 1996) and therefore in 24 hr and 48 
hr models, incubation without 1400W means that the tissue is exposed to 
significant levels of NO until 1400W is added to the organ bath. This is likely to 
affect the outcome of the experiment if NO has injurious effects on the tissue, 
such as nitration (Giannopoulou et al., 2002) or nitrosylation (Dalle-Donne, 
2000). Significantly, 1400W has a slow time of onset (Garvey et al., 1997), but 
this should not be an issue once co-incubated with tissue and LPS in my 24 hr and 
48 hr experiments. To exclude the possibility of a washout effect in the future, 
1400W should be co-incubated and subsequently added again in the organ bath 
prior to investigation with PE and levcromakalim.  
 
Other possibilities for the absence of inhibition of hyporeactivity to LPS (fig. 4.1 
A) could include insufficient concentrations of NADPH in the tissue, as NADPH 
is an essential cofactor for 1400W, without which its efficacy is profoundly 
reduced (Garvey et al., 1997). Additionally, 1400W may have had toxic effects on 
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small quantities of tissue, contributing to the very abnormal concentration-
response curves seen in mesenteric artery (fig. 4.2 B). Older iNOS inhibitors, such 
as the bisisothioureas, can be quite toxic (Garvey et al., 1997), but this has so far 
not been observed with 1400W (Garvey et al., 1997). 
 
The lack of potentiation of levcromokalim in the presence of Deta NO (fig 4.6) 
may have been due to inadequate concentrations of Deta NO, but as described 
above, the levels of nitrite measured (fig. 4.4) do not support this. However, it is 
possible that for NO to abnormally open the KATP channel, the presence of other 
factors such as LPS itself, IL-1 and/or TNF alpha are required. 
 
Finally, the initial observation that levcromokalim-induced relaxation was not 
potentiated meant that the Deta NO model could not be followed up. In future, 
should the model be refined to be able to reproduce this, then further experiments 
using cGMP and PKG inhibitors would be necessary, to be able to conclude that 
this was a direct NO effect on the channel. Examination of the nitration and 
nitrosylation status of the KATP channel protein would then offer further 
confirmation. 
 
In conclusion, there is good evidence that NO production is involved in the 
abnormal opening of the KATP channel in sepsis (O’Brien et al., 2001; Wilson, 
2002), but the exact mechanism is unknown. I have been unable to demonstrate 
that this is a direct NO effect. It is possible that NO opens the KATP channel via 
multiple mechanisms, including the cGMP/PKG pathway (Han et al., 2002), with 
Does NO directly alter KATP channel function in sepsis? 
 150 
phosphorylation of the channel protein (Han et al., 2002). Increased channel 
expression is also likely to play a role (Shi et al., 2010).
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Chapter Five 
 
 
Does an altered metabolic state  
cause KATP channel dysfunction  
in an in vivo model of sepsis? 
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5.1 Vascular hyporeactivity in an in vivo model of sepsis 
The in vivo model of sepsis was used to study the role of the KATP channel in 
sepsis, specifically its role in sepsis-induced vascular hyporeactivity. For each of 
the animals used, the thoracic aorta was removed and frozen in liquid nitrogen, as 
per the protocol described in Chapter Two (section 2.11). This tissue was later 
used to measure levels of the nucleotides ATP, ADP and AMP in the blood vessel 
wall. The abdominal aorta was removed and placed in Hanks’ Balanced Salt 
Solution (Invitrogen, Paisley, UK), buffered with 2mM bicarbonate and 10 mM 
HEPES, as per O’Brien et al. (2001). This fresh tissue was then mounted in the 
organ bath to further investigate the pharmacology of the KATP channel.  
 
Figure 5.1 demonstrates that the vessels were hyporeactive to PE at both the 24 hr 
(fig 5.1A) and 48 hr (fig. 5.2A) time points. The control vessel concentration-
response curve was significantly different from the septic concentration-response 
curve at both the 24 hr and 48 hr time points. The relaxation concentration-
response curves to levcromakalim were also significantly shifted to the left, 
demonstrating an increased ability of levcromakalim to open the KATP channel in 
sepsis (fig. 5.1B and 5.2B, respectively). This is consistent with previous work 
showing this phenomenon (Chen et al, 2000; O’Brien et al, 2005). 
 
These experiments demonstrate that a greater open probability of the KATP 
channel in septic abdominal aorta in this in vivo model of sepsis, and that this 
contributes to vascular hyporeactivity. There was potentiation of levcromakalim-
induced relaxation which was significant at the 24 hr time point, but not at 48 hr.  
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Fig 5.1. Ex vivo assessment of aortic vascular reactivity after 24 hr of in vivo 
sepsis (faecal peritonitis) in a rat model. A. Concentration-response curves to 
phenylephrine in rings of abdominal aorta taken from sham (n=4, EC50 9.1.10-8 
M) and septic animals (n=8, EC50 6.6.10-8 M) (P < 0.005, *). B. Concentration-
response curves of levcromakalim in rings of abdominal aorta taken from sham 
(n=4, EC50 3.4.10-7 M) and septic animals (n=8, EC50 1.9.10-7 M) (P < 0.005, *). 
Data are displayed as mean ± SEM. * Points statistically significantly different. 
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Fig 5.2. Ex vivo assessment of aortic vascular reactivity after 48 hr of in vivo 
sepsis (faecal peritonitis) in a rat model. A. Concentration-response curves to 
phenylephrine in rings of abdominal aorta taken from sham (n=4, EC50 1.7.10-7 
M) and septic animals (n=8, EC50 1.5.10-7 M) (P < 0.005, *). B. Concentration-
response curves of levcromakalim in rings of abdominal aorta taken from sham 
(n=4, EC50 1.7.10-7 M) and septic animals (n=8, EC50 1.1.10-7 M) (P > 0.05). Data 
are displayed as mean ± SEM. 
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I subsequently used this model as a basis for further experiments testing two 
hypotheses: 
1) That the open state of the channel was due to an abnormality in the control of 
the ion channel pore by the SUR (Wilson & Clapp, 2002). 
2) That the open state of the KATP channel in sepsis was due to either a decrease in 
the ATP level in the vascular smooth muscle cells, and/or an increase in ADP, 
with a consequent decrease in ATP: ADP ratio. 
 
5.2 Abnormal control of the ion channel pore by the SUR 
The pharmacology of the channel alters in sepsis, whereby the ability of 
glibenclamide to close the channel is lost yet that of the pore-blocking drugs is 
retained (Wilson & Clapp, 2002). I initially sought to verify this phenomenon by 
using the specific pore-blocking agent PNU-37883A and the sulphonylurea 
receptor inhibitor, glibenclamide to reverse the relaxation caused by the KATP 
channel opener levcromakalim in rings of abdominal aorta taken from the in vivo 
model of sepsis. If KATP channel pharmacology is altered in sepsis by affecting the 
sulphonylurea receptor, then PNU-37883A should be more effective in improving 
vascular reactivity, because its action is not dependent on the SUR as it binds to 
the ion channel pore directly. The results of these experiments are shown in Figs. 
5.3 and 5.4. Both PNU-37883A and glibenclamide were used at 10µM 
concentration (adapted from O’Brien et al., 2005). At 24 hr, PNU-37883A only 
partially reversed levcromakalim-induced relaxation, with a significant difference 
between septic and sham tissue (Fig. 5.3; 38% vs 90%, P < 0.05). However, at 48 
hr, the ability of PNU-37883A to fully reverse relaxation was restored, with no 
Metabolic state in an in vivo model of sepsis 
 156 
difference seen between sham and septic responses (Fig. 5.3, 82% vs 90%, P > 
0.05).  
 
 
 
 
 
 
 
Fig 5.3 Percentage reversal of levcromakalim-induced relaxation by the pore 
inhibitor PNU-37883A in aortic rings taken from the in vivo sepsis model. 
Data displayed as mean ± SEM. There was a significant reduction in the ability of 
PNU-37883A (10 µM) to reverse levcromakalim-induced (3 µM) relaxation in 
aorta taken from septic animals at 24 hr (90% vs 38%, P < 0.05). No difference 
was seen at 48 hr. 
 
 
P < 0.05 
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Fig 5.4 Percentage reversal of levcromakalim-induced relaxation by the 
sulphonylurea inhibitor, glibenclamide in aortic rings taken from the in vivo 
model. Data displayed as mean ± SEM. There was a significant reduction in the 
ability of glibenclamide (10 µM) to reverse levcromakalim-induced (3 µM) 
relaxation in aorta taken from septic animals at 24 hr (51% vs 6%, P < 0.05) but 
not at 48 hr (24% vs 30%). 
 
Comparison of PNU-37883A and glibenclamide responses is shown in Fig 5.5. In 
aorta taken from 24 hr sham animals, PNU-37883A fully reversed 
levcromakalim-induced relaxation (90%) compared to glibenclamide (50%) 
though this difference was not significantly different (P > 0.05). The degree of 
reversal by both drugs was significantly different at 24 hr for septic tissue (38% 
vs 6%, P < 0.05) and at 48 hr for both sham (82% vs 30%, P < 0.02) and septic 
(94% vs 24%, P < 0.001) tissue. 
P < 0.05 
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Fig 5.5 Percentage reversal by PNU-37883A (10 µM) or glibenclamide 
(10µM) of levcromakalim-induced relaxation in rings of abdominal aorta 
taken from the in-vivo model. Analysed using 1-way ANOVA. All significant 
differences are annotated, all other comparisons were non-significant (P > 0.05). 
Data displayed as mean ± SEM.  
 
These experiments assessed the ability of the KATP channel pore blocker PNU-
37883A to reverse levcromakalim-induced relaxation. While PNU-37883A only 
partially reversed relaxation in 24hr septic tissue, it fully reversed relaxation at 48 
hr. Glibenclamide reversal of relaxation was significantly reduced in 24 hr septic 
tissue, but there was some degree of recovery in 48 hr septic tissue. I also found 
that PNU-37883A was more potent at reversing levcromakalim-induced 
relaxation than glibenclamide in all tissues. This difference was greater in septic 
tissue, supporting the hypothesis that pore-blocking drugs are more effective at 
closing the KATP channel in sepsis compared to drugs acting via the SUR subunit.  
P < 0.05 * 
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5.3 Adenine nucleotide levels in vascular smooth muscle in an in vivo model 
of sepsis 
Adenine nucleotides are important regulators of KATP channel function (Nelson & 
Quayle) and these levels are altered in sepsis (Brealey, 2004). Therefore, I carried 
out a series of experiments to measure adenine nucleotides in aorta from the in 
vivo model of sepsis to determine if alterations in ATP, ADP or AMP were 
associated with the altered KATP channel function observed in sepsis. 
 
Standard curves were generated for each of the nucleotides (ATP, ADP and 
AMP). Additionally, tissue samples were spiked with nucleotides to internally 
validate the method. 
 
 
Fig. 5.6: Standard curve for ATP concentration (nM) measured using HPLC. 
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Fig 5.7: Standard curves for A. ADP and B. AMP concentration (nM) measured 
using HPLC. 
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Fig. 5.8. HPLC measurement of adenine nucleotide levels in rat aorta, spiked 
with an additional 100 µM ATP, ADP and AMP. 
 
The thoracic aortae were removed from deeply anaesthetised rats as described in 
chapter two (section 2.3). These samples were then flash-frozen in liquid nitrogen, 
freeze-dried and homogenised, prior to processing for HPLC. The samples were 
processed via high performance liquid chromatography, (see section 2.12). Using 
1-way ANOVA, no significant change in ATP concentration was seen at either 24 
hr (p > 0.05) or 48 hr (p > 0.05) (Fig 5.9). 
 
No significant changes were seen in ATP levels when the animals were divided 
into mild, moderate and severe sepsis groups however numbers in each group 
were probably too small to address this question adequately (Fig. 5.10). 
Metabolic state in an in vivo model of sepsis 
 162 
Nevertheless, abdominal aorta removed concurrently did demonstrate marked 
vascular hyporeactivity, so low energy levels of ATP are unlikely for this. 
 
A similar pattern was seen for ADP and AMP levels in sepsis (Figs. 5.11 and 
5.13, respectively). A trend towards a decrease in ADP and AMP levels were seen 
in the 48 hr severe sepsis group (Fig. 5.12), though, using 1-way ANOVA, this 
did not reach statistical significance (P > 0.05). 
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Fig. 5.9: ATP levels from thoracic aorta, normalised to mg dry weight of 
tissue. No significant difference was seen between naïve animals and sham 
animals, or between sham and septic animals at any time point (P > 0.05). Data 
are displayed as mean ± SEM. 
 
Fig. 5.10: ATP levels from thoracic aorta, normalised to mg dry weight of 
tissue. Using 1-way ANOVA, no significant difference was seen between any 
groups (P > 0.05). Data displayed as mean ± SEM. 
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Fig. 5.11: ADP levels from thoracic aorta, normalised to mg dry weight of 
tissue. Using 1-way ANOVA, no significant difference was seen between any 
groups (P > 0.05). Data displayed as mean ± SEM. 
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Fig. 5.12: ADP levels from thoracic aorta, normalised to mg dry weight of 
tissue. 
Using 1-way ANOVA, no significant difference was seen between any of the 
groups (P > 0.05). Data are displayed as mean ± SEM. 
Fig. 5.13: AMP levels from thoracic aorta, normalised to mg dry weight of 
tissue. Using 1-way ANOVA, AMP levels were raised at 48hr sepsis when 
compared to 48hr sham (P < 0.01). Data are displayed as mean ± SEM. 
 
P < 0.01 
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Fig. 5.14: AMP levels from thoracic aorta, normalised to mg dry weight of 
tissue. No significant difference was observed in AMP levels from aortae taken at 
24 hr from sham animals, and septic animals from all severity groups, 1-way 
ANOVA, P > 0.05. At 48 hr the AMP level in the moderate severity group was 
significantly elevated when compared to 48hr sham only (P<0.05). Data are 
displayed as mean ± SEM. 
 
These experiments demonstrated no significant difference in adenine nucleotide 
levels in thoracic aorta taken from this rat peritonitis model of sepsis compared to 
sham animals. Vascular hyporeactivity (fig. 5.1) and altered KATP channel 
pharmacology (fig. 5.5) have however been demonstrated in these tissues. 
 
I therefore proceeded to measure adenine nucleotide levels in thoracic aorta from 
an in vitro model of sepsis, as described in Chapter two. Previous experiments 
demonstrating altered pharmacology of the KATP channel (Wilson & Clapp, 2002; 
O’Brien et al, 2005) have not been repeated. 
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5.4 Adenine nucleotide levels in vascular smooth muscle in an in vitro model 
of sepsis: 
ATP, ADP and AMP levels were measured in thoracic aorta incubated in DMEM 
± LPS (100 ng.ml-1) for 24 and 48 hr periods. The thoracic aortae were obtained 
as described in Chapter Two. The samples were processed via high performance 
liquid chromatography, again as described in Chapter Two. Levels of ATP were 
unaltered with sepsis (Fig. 5.15). ADP levels were un-interpretable with many 
negative values being obtained (data not shown). AMP levels were significantly 
reduced in all septic tissues and in control tissue, compared to naive tissue (Fig 
5.16).  
 
 
Fig. 5.15: ATP levels from thoracic aorta from an in vitro model of sepsis, 
normalised to mg dry weight of tissue. Using 1-way ANOVA, no significant 
difference was seen between samples (P > 0.05). Data displayed as mean ± SEM. 
 
 
n = 4 n = 4 
n = 3 n = 4 
n = 4 
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Fig. 5.16: AMP levels from rat thoracic aorta, normalised to mg dry weight 
of tissue, in an in vitro model of sepsis. A significant difference was observed 
between naïve animals and all other groups (P < 0.01), with the exception of the 
48 hr sham group (P > 0.05). No significant difference was seen between any of 
the 24 hr or 48 hr tissue values (P > 0.05). Data displayed as mean ± SEM. 
 
These experiments demonstrated that ATP levels in rings of rat thoracic aorta 
were unchanged in an in vitro model of sepsis, possibly with a trend towards a 
reduction at the 48 hr sepsis time point. However, levels of ADP in the tissue 
were almost non-existent. Incubation of tissue in DMEM ± LPS caused a 
significant reduction in levels of AMP measured in the tissue.  
 
 
 
P < 0.01 
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5. 5 Discussion 
With the use of HPLC, I demonstrated that there was no alteration in the levels of 
ATP in either an in vivo or in vitro model of sepsis. This was despite 
demonstrating that the tissue used was a valid model via the proven, altered 
pharmacology of the KATP channel. It is possible that the levels of ATP were 
altered, but the method used was too insensitive to measure it. Alternatively, it 
may be sub-cellular, compartmentalised ATP that varies in sepsis, thus altering 
the KATP channel. These results were surprising, considering that ATP is such a 
potent controlling mechanism of the channel, and that clinical studies have shown 
altered levels of KATP in sepsis (Brealey et al., 2002). However, this was 
demonstrated in skeletal muscle, not in vascular smooth muscle. 
 
Measurements of adenine nucleotides were more reproducible in the in vivo 
model of sepsis. This may have been simply due to the fact that the in vivo model 
meant that a whole thoracic aorta could be homogenised each time, thereby 
reducing the amount of error due to dilution. The in vitro model required the 
incubation of rings of aorta in DMEM ± LPS. Therefore, it is possible that the 
rings of vessel were too small to accurately measure adenine nucleotides. 
Alternatively, adenine nucleotides are better preserved and maintained in the in 
vivo model, hence potentially strengthening the validity of such models over in 
vitro models. All the more so since I clearly demonstrated altered KATP channel 
pharmacology in the in vivo model.  
 
There was a significant increase in AMP levels in septic tissue and has important 
implications for the metabolic state of the cell and subsequently KATP channel 
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function. It is possible that it represents increased ATP and ADP breakdown, in 
the attempt of the cell and tissues to maintain sufficient ATP levels for overall 
cellular function. The very low levels of ADP measured in the in vitro model may 
be real. However, in view of the abnormally low levels measured in the naive 
samples, I suspect that it was more likely artefactual, and ideally should be 
repeated. However, the overall pattern of results suggests that the technique is not 
reproducible in small rings of tissue, with low levels of total protein. 
Measurement of sub-cellular levels of adenine nucleotides, in the context of 
patch-clamp studies or rubidium efflux experiments would potentially offer 
interesting information on the metabolic alteration of the cell and KATP channel in 
sepsis, however, the above difficulties may be even more exaggerated.   
 
The KATP channel links the metabolic state of the cell to membrane potential and 
vascular tone. In sepsis this channel is abnormally activated. Intracellular ATP 
inhibits channel activity. Lower ATP levels are seen in skeletal muscle of 
eventual non-survivors of septic shock when compared to eventual survivors 
(Brealey et al., 2002). This is associated with mitochondrial dysfunction with the 
degree of inhibition of complex I correlating with the clinical severity of illness 
and with NO production (Brealey et al., 2002). Indeed, the effect of NO on KATP 
channels in the pancreas is secondary to decreased ATP via inhibition of 
phosphofructokinase (Tsuura et al., 1994). The concept of mitochondrial 
dysfunction is supported by the inhibition of mitochondrial function seen in 
human umbilical vein epithelial cells incubated with serum from septic patients 
(Boulos et al., 2003). This is not surprising as NO and its metabolites (including 
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peroxynitrite) have been shown to inhibit complexes I and IV of the 
mitochondrial respiratory chain (Brown et al., 1994; Clementi et al., 1998). 
 
It is well recognised that gross metabolic abnormalities occur in septic shock, 
which contribute to the development of multi-organ failure. Some of these effects 
may be related to alterations in tissue oxygen utilisation. A low oxygen 
consumption has been observed in patients with severe sepsis, with a better 
prognosis in those achieving higher values of global oxygen delivery and 
consumption (Pollack et al., 1985). However, septic patients and (well-
resuscitated) animal models often demonstrate an increase in tissue oxygen 
tension (Boekstegers et al., 1991; Rosser et al., 1996). This suggests adequate 
delivery, but impaired utilisation of oxygen. As greater than 90% of oxygen 
consumed by the body is for mitochondrial generation of ATP via oxidative 
phosphorylation, mitochondrial dysfunction is therefore implied (Singer et al., 
1999). 
 
In primate and rat models of sepsis, morphological evaluation of mitochondria by 
electron microscopy has shown swelling and distortion of the mitochondrial 
structure, including disruption of the matrix (Kantrow et al., 1997; Simonson et 
al., 1994). These structural changes were associated with a decrease in cellular 
oxidative capacity and a progressive loss of mitochondrial cytochrome c oxidase 
function. In other studies, decreases in mitochondrial respiration and cytosolic 
ATP levels have been reported but generally only in longer term (>16 hr) 
endotoxic models (Singer et al., 1999). 
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Figure 5.17: Cartoon illustrating a potential mechanism by which endotoxin 
opens the KATP channel both in the membrane of cells and in the mitochondrial 
membrane, thus inducing mitochondrial dysfunction and, potentially, multiorgan 
failure (Buckley et al., 2006). Conversely, one mechanism by which insulin could 
exert its beneficial effects in sepsis may be by opening mitochondrial KATP 
channels, but when the cell is in a physiologically preserved metabolic state.  
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Matrix volume is considered to be an important regulator of mitochondrial 
metabolism (Halestrap, 1994). The main factor determining mitochondrial volume 
is the balance between K+ fluxes across the inner membrane and the passage of 
anions and water. K+ homeostasis, in turn, is maintained by influx of K+ through 
electrochemically driven uniporters and K+ efflux through the K+/H+ exchanger. 
KATP channels have also been found in the inner mitochondrial membrane (Inoue 
et al., 1991) and evidence suggests that these channels regulate mitochondrial K+ 
influx (Jaburek et al., 1998; Szewczyk et al., 1996). Observations that 
glibenclamide and ATP inhibit mitochondrial swelling, whereas potassium 
channel openers potentiate swelling suggest that KATP channels play a key role in 
volume regulation (Holmuhamedov et al., 1998; Szewczyk et al., 1996). Since 
KATP channels would open secondary to falling ATP levels and/or increases in 
nucleotide diphosphates, these channels may well become activated during sepsis. 
In addition, opening of K+ channels in mitochondria increases respiration, and 
slows down the production of ATP by the mitochondria. This and the increased 
cytosolic cytochrome c are indicators or apoptosis (Holmuhamedov et al., 1998). 
The potential role that this plays in sepsis is rather more difficult to understand, 
but may indicate increased apoptosis. 
 
Overproduction of NO appears to contribute to mitochondrial dysfunction; either 
through direct interaction with components of the electron transfer chain and/or 
indirectly through KATP channel activation. It has recently been reported that NO 
can directly compete with oxygen to inhibit cytochrome c oxidase and complex 
IV activity (Brookes et al., 1999; Brown, 1997). It was postulated that some of 
these effects might be related to the formation of peroxynitrite, a highly oxidising 
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metabolite of NO. Furthermore, NO has been shown to cause membrane 
depolarisation in liver mitochondria, although the mechanism for this remains to 
be elucidated (Schweizer et al., 1994).  
 
Tight control of glucose levels with insulin infusion has been shown to reduce the 
mortality of surgical patients from MOF secondary to septic shock (van den et al., 
2001), and this may be due to either tighter glycaemic control or the insulin 
infusion. Insulin plays a key role in cardiomyocyte protection from ischaemia-
reperfusion injury  (LaDisa et al., 2004); and this acts via several mechanisms, 
including protein tyrosine kinase, phosphatidylinositol-3- kinase p70s6 kinase, 
NO pathways (Gao et al., 2002; Jonassen et al., 2001) and via an actin 
cytoskeleton-dependent mechanism (Shimoni et al., 1999). Conversely, 
hyperglycaemia has been shown to promote apoptosis via activation of p53 (via 
O-glycosylation) and p38 MAP-kinases (Fiordaliso et al., 2001). Not only does 
insulin protect against ischaemia-reperfusion, but it may also be involved in 
ischaemic preconditioning via KATP channels activation (Gross et al., 1992) with 
the mitochondrial KATP channels playing an important role, via a PKC-dependent 
pathway (Takashi et al., 1999).  
 
In considering sepsis and ischaemic preconditioning, it may be helpful to firstly 
consider them as opposite ends of the same spectrum. Ischaemic preconditioning 
is the promotion of cell survival in a low oxygen state by the prior opening of the 
mitoKATP channel (Fiordaliso et al., 2001; Gross et al., 1992; Gross et al., 2000; 
Holmuhamedov et al., 1998; Jonassen et al., 2001; LaDisa et al., 2004; Takashi et 
al., 1999). Conversely, the beneficial effects of insulin in sepsis may well be 
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secondary to the closing of the mitoKATP in a high oxygen state (with reduction of 
apoptosis), albeit due to decreased oxygen utilisation and not to a decrease in 
oxygen delivery (Boekstegers et al., 1991; Rosser et al., 1996; Singer et al., 
1999). It may therefore be interesting to study the phenomenon of ischaemic 
preconditioning during sepsis. One would postulate that the effect is abolished. 
However, the beneficial effects of insulin in ischaemic preconditioning are 
apparently linked to the opening of the KATP channel in cardiac myocytes (LaDisa 
et al., 2004). This contradicts the hypothesis that insulin closes the mitoKATP in 
sepsis. Therefore, the alternative is that insulin opens the mitoKATP in sepsis as 
well as in ischaemic preconditioning, with sepsis also being seen as a 
“functionally” low oxygen state, with increased glycolysis. This is supported by 
the normal histological findings of organs taken from patients who died of 
multiorgan failure secondary to sepsis (Hotchkiss et al., 2003). 
 
Insulin is known to enhance KATP channel function in both neurons (Spanswick et 
al., 2000) and rat skeletal muscle (Tricarico et al., 1997), resulting from a 
decreased sensitivity to ATP (Tricarico et al., 1997). However, unlike the survival 
of surgical patients with sepsis (van den et al., 2001), the survival of ischaemic 
myocardium is independent of blood glucose concentration (LaDisa et al., 2004; 
Jonassen et al., 2001). KATP channels in the pancreas have been shown to be 
inhibited by increases in glucose levels that are within the physiological range 
(Misler et al., 1989). 
 
It is possible that insulin somehow regulates the mitochondrial KATP channels and 
thereby maintaining mitochondrial and organ integrity, and preventing the organ 
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from entering a state of bioenergetic/metabolic shut-down. However, the evidence 
is conflicting, with some research showing that insulin keeps the KATP channel 
open, and that this is associated with increased survival (LaDisa et al., 2004; 
Tricarico et al., 1997; van den et al., 2001), whilst others show that opening of 
KATP channels in mitochondria is associated with apoptosis (Holmuhamedov et 
al., 1998). The majority of the evidence for preventing cell death is based on 
studies using cardiomyocytes, whereas promotion of apoptosis comes from other 
tissues, namely neuronal (Yu et al., 1997) and pancreas. Indeed, the closure of 
KATP channels in eosinophils reduces their survival (Bankers-Fulbright et al., 
1998); one could postulate that this is a component of a mechanism for down-
regulating the inflammatory response in sepsis. One crucial factor in the role of 
insulin is the timing of its administration, with protection if administered early in 
ischaemia-reperfusion injury and no effect on infarct size if administered 15 
minutes into reperfusion (Jonassen et al., 2001). Further research is needed to 
examine if the protective effects of insulin reducing multiorgan failure in sepsis 
are secondary to its effects on the mitochondrial KATP channels of the organs at 
risk. 
 
Many of the features of sepsis contribute to its high mortality rate. However, the 
aetiology of the vascular hyporeactivity that is seen is not yet fully understood. 
The role of the KATP channel in vascular hyporeactivity means that the energy 
state of the cell, tissue and whole organism probably has an important role to play. 
In keeping with this is the decreased mortality seen in septic shock with the use of 
insulin the maintenance of blood glucose levels within 4-6 mmolL-1 (van den et 
al., 2001). The role of the KATP channel in sepsis is unlikely to be limited to the 
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vasculature and may well also have a fundamental role to play in the function of 
mitochondria and multi-organ failure. 
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6.1 Discussion 
The most severe manifestation of sepsis-induced cardiovascular dysfunction is 
septic shock, a condition defined as organ dysfunction/perfusion abnormalities 
plus hypotension (or a drop in systolic blood pressure >40 mmHg) that has not 
responded to adequate fluid resuscitation. This results from a combination of 
excessive vasodilatation, vascular hyporeactivity (i.e. decreased responsiveness to 
catecholamines) and variable degrees of myocardial depression. Knowledge of the 
underlying mechanisms of shock will enable a more focused therapeutic strategy. 
 
One such target is the KATP channel, an ion channel critical in the cardiovascular 
adaptive response to stress. Pharmacological opening of these channels is already 
used therapeutically to treat angina pectoris (e.g. nicorandil) while inhibitors (e.g. 
glyburide) are used in type II diabetes (Seino & Miki, 2003; Rodrigo & Standen, 
2005). Excessive activation of the vascular channel is now recognised as a major 
cause of hypotension and vascular hyporesponsiveness to catecholamines in septic 
shock (Sorrentino, 1999; Landry, 2001; Warrillow et al., 2006). This has led some 
researchers to advocate therapeutic blockade of these channels (Warrillow et al., 
2006) and this may indeed underlie the mechanism of vasopressin in refractory 
shock (Barrett et al., 2007). However, outside the vasculature, channel opening 
may actually represent a protective mechanism against cellular damage (Kaneko, 
2005; Otani, 2003).  
 
The aim of my thesis was to examine the role of the KATP channel in the context 
of sepsis, with particular reference to the actin cytoskeleton, nitric oxide and the 
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metabolic state of the tissue. I demonstrated altered KATP channel pharmacology 
in both an in vitro and in vivo model of sepsis, similar to that seen in published in 
vitro models (Sorrentino, 1999; O’Brien, 2001; Wilson & Clapp, 2002). I have 
demonstrated that it is possible to study the actin cytoskeleton in a semi-
quantitative fashion. The development of the method to semi-quantify the actin 
cytoskeleton in tissue means that other scientists can evaluate and develop their 
techniques from this. By attempting to solve some of the problems with confocal 
microscopy of tissue (thickness of tissue sections, immunohistochemistry 
protocols, image acquisition and analysis protocols) others will either decide that 
this is an inappropriate technique to answer this question or develop further. The 
confocal method I finally developed was more reproducible than some of my 
earlier attempts, with an assessment of a more representative sample. Equally, I 
developed an objective and reproducible method of image analysis, trying to 
make it semi-quantifiable. I also developed a novel biochemical technique for the 
separation of F and G actin in vascular smooth muscle tissue and semi-quantified 
this using Western blot. I performed measurement of adenine nucleotides in 
vascular smooth muscle tissue and to my knowledge, this is the first time this has 
been undertaken.  
 
My data demonstrated that there was not a clear relationship between structure 
and function in the in vitro model of sepsis and that cytoskeletal disruption does 
not cause the altered pharmacology of the vascular KATP channel in sepsis. 
Additionally, a direct effect of nitric oxide on the KATP channel does not explain 
the changes observed. Finally, substantial changes in the cellular ATP:ADP:AMP 
ratio in the tissue does not underlie KATP channel dysfunction. 
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6.2 Implications for the vascular biology of sepsis 
Confocal microscopy may be the wrong tool with which to quantify the actin 
cytoskeleton in tissue, partly because of the density and structure of the tissue. 
Confocal microscopy would be a powerful tool in the assessment of actin stress 
fibre rearrangement in VSMCs. This could be combined with patch clamp 
techniques, thereby analysing and correlating the structure and electrophysiology 
of VSMCs. For instance, one could examine the arrangement of actin, manipulate 
proteins (e.g. syntaxin 1a) and look at calcium flux and membrane 
electrophysiology. However, one of the strengths of my methods was that doing 
microscopy on tissue meant that I was able to utilise a well established method for 
assessing the function of vascular tissue in sepsis, namely the organ bath 
assessment of tension. This is clearly the most direct and clinically relevant 
assessment of vascular tissue. I do believe that Western blotting is a useful 
technique for assessing the actin cytoskeleton in tissue and I have developed a 
novel technique for the separation of F and G actin. However, I believe that 
Western blotting is, at best, a semi-quantifiable technique. If there had been a 
dramatic (>50 %) change in levels of F actin in vascular smooth muscle in my 
model of sepsis, I believe that my methods would have picked up such a change. 
 
The inability to replicate altered KATP channel pharmacology using Deta NO 
provides important information about the in vitro model. It would be interesting to 
repeat the experiments using L-arginine (Wilson, 2001) or cGMP analogues and 
inhibitors (Han et al., 2002). Measurement of nitrated proteins in the tissue, in 
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addition to nitrite, would be very interesting, and would indicate if the NO 
released by Deta NO had pathological consequences.  
 
The KATP channel is opened excessively in models of sepsis (Hall et al., 1996; 
Sorrentino et al., 1999; Chen et al. 2000). However, the actual pharmacology of 
the channel is also altered, in that it can no longer be closed by inhibitors acting 
via the SUR, but can be closed by inhibitors acting via the ion channel pore 
(O’Brien et al., 2005) and the effects of KCOs are potentiated (O’Brien et al., 
2001). KCOs increase the open probability of the channel by creating a 
conformational change in the SUR. This conformational change requires the 
presence of Mg++ADP being bound to the NBF. Glibenclamide and other 
sulphonylureas inhibit binding of KCOs to the SUR (Dickinson, 1997; Hambrock, 
1998; Loffler-Walz, 1998; Schwanstecher, 1998) by causing a conformational 
change in the SUR and by preventing binding of Mg++ADP to the NBFs. This 
then allows the inhibitory effect of ADP on the Kir to tip the balance of the KATP 
channel to the closed state (Bryan, 1999). The inhibitory effect of ADP on the Kir 
requires the presence of the 10 residues on the N-terminus of the Kir 6.2, as the 
deletion of this eliminates the ability of tolbutamide to exert its inhibitory effect 
(Bryan, 1999). ATP inhibits the channel by binding to the interface between two 
Kir subunits within the tetramer, interacting with the C-terminus of one subunit 
and the N-terminus of another (Antcliff, 2005). 
 
This SUR subunit may well be the region of the KATP channel affected in sepsis 
secondary to either nitration (Giannopolou, 2000), nitrosylation (Danne-Dolle, 
2000), cytoskeletal disruption (Terzic & Kurachi) or other mechanisms such as 
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alteration of the Transmembrane Binding Domain (TMD) 1-5 M2 link or the 
TMD1-5 N-terminus link. 
 
Closure of the KATP channel in sepsis has been a research and therapeutic goal for 
over a decade. However, our current understanding of sepsis, shock and MOF 
suggests that maintenance of microvascular flow and organ perfusion may be 
critical. Microvascular flow is reduced in patients with sepsis (De Backer et al., 
2002). Organ hypoperfusion and subsequent tissue hypoxia may play a role in the 
development of multiorgan failure (Bateman & Walley, 2005). Microvascular 
flow recovers rapidly in survivors of sepsis when compared to non-survivors 
(Bateman & Walley, 2005). Therefore, there may be a role for using therapeutic 
interventions to open the KATP channel in sepsis to improve microvascular flow 
and prevent organ failure. This could be therapeutically achieved by insulin, 
which opens KATP channels in the myocardium, preventing damage from 
ischaemia (LaDisa et al., 2004). In support of this is the finding that the loss of the 
KATP channel decreases survival in Kir6.1 knockout mice in an LPS model of 
sepsis (Kane et al., 2006). This makes it clear that the response that the KATP 
channel confers in sepsis has a distinct survival advantage, at least in animals 
(Kane et al., 2006). The involvement of KATP channels in the vascular 
disturbances of sepsis was also questioned in a recent blinded, placebo-controlled 
study in shocked patients where glyburide had no effect on blood pressure or 
norepinephrine requirements (Warrillow et al., 2006). This is at odds with 
historical in vivo literature, but probably reflects the failure of SUR inhibitors at 
standard therapeutic concentrations to block the open channel during periods of 
metabolic stress, such as sepsis. Therefore, understanding what opens the channel 
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may well be critical for future progress in critical care patients with sepsis, shock 
and MOF.  
 
Crucially, I believe the role that insulin plays, as well as the mitochondrial KATP 
channel, are fundamental to our future understanding and should be investigated 
further, to better understand and better target our clinical and therapeutic 
strategies. 
Insulin is known to enhance KATP channel function in both neurons (Spanswick et 
al., 2000) and rat skeletal muscle (Tricarico et al., 1997), resulting from a 
decreased sensitivity to ATP (Tricarico et al., 1997). It is possible that insulin 
somehow regulates the mitochondrial KATP channels and thereby maintaining 
mitochondrial and organ integrity, and preventing the organ from entering a state 
of bioenergetic/metabolic shut-down. The majority of the evidence for preventing 
cell death is based on studies using cardiomyocytes, whereas promotion of 
apoptosis comes from other tissues, namely neuronal (Yu et al., 1997) and 
pancreas. However, the evidence is conflicting, with some research showing that 
insulin keeps the KATP channel open, and that this is associated with increased 
survival (LaDisa et al., 2004; Tricarico et al., 1997; van den et al., 2001), whilst 
others show that opening of KATP channels in mitochondria is associated with 
apoptosis (Holmuhamedov et al., 1998). Further research is needed to examine if 
the protective effects of insulin reducing multiorgan failure in sepsis are 
secondary to its effects on the mitochondrial KATP channels of the organs at risk. 
This could be investigated in animal models of sepsis, with ex vivo assessment of 
mitochondrial KATP channels. Additionally, the timing of insulin may be critical, 
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with infusions early in sepsis, prior to the development of organ failure being 
potentially important. 
 
6.3 Summary and Conclusion 
Sepsis has a very high mortality rate and yet we still do not have a clear 
understanding of the pathophysiological processes involved. Vascular 
hyporeactivity is an important component of sepsis and we are only beginning to 
gain an understanding of its aetiology. In addition to many other mechanisms, 
KATP channels play a fundamental role in vascular hyporeactivity in long-term 
sepsis. The precise mechanism of their activation has yet to be elucidated. 
Excessive activation of the KATP channel is implicated in a number of crucial 
mechanisms including vascular hyporeactivity, hypotension, insulin resistance 
and mitochondrial dysfunction. However, as discussed previously, KATP channel 
opening may also afford a degree of protection.  Realistically, the KATP channel is 
only one of the many mechanisms underlying vascular hyporeactivity in sepsis 
and therefore targeting it therapeutically is unlikely to be the “silver bullet” for 
septic shock. However, a greater understanding of the pathophysiology underlying 
its activation can only bring us closer to the day when we can significantly reduce 
the mortality from sepsis. 
 
6.4 Future Directions 
My research would be strengthened by the following experiments: 
1. Confocal microscopy to examine the actin cytoskeleton at the single cell 
level in a tissue-culture model of sepsis. 
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2. Electrophysiological studies in VSMCs, including examining the role of 
the syntaxin family of proteins. 
3. Repetition of ATP, ADP and AMP measurement in an in vitro model of 
sepsis. 
4. Examination of actin cytoskeleton in mesenteric artery to complement my 
experiments, especially with a validated control, which does not interfere 
with actin proteins. 
5. Examination of the effects of sepsis on the mitochondrial KATP channel. 
6. Further exploration of the NO/cGMP pathway, downstream of NO, and its 
effects on the KATP channel in sepsis, including calcineurin, PKC and 
PKA. 
7. Examination of insulin’s role in an in vivo and in vitro model of sepsis, 
specifically in the organ bath model, to explore the effects on channel 
pharmacology. 
8. Examination of renal, hepatic and cardiac metabolism/ O2 tension in an in 
vivo model of sepsis, with modulation of KATP channel pharmacology ± 
insulin. 
9. Specific examination of mitochondrial function in the above experiments 
(6). 
10. Specific examination of 7 and 8 above in a Kir6.1 mouse knockout model.
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